Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

RGD DISEASE ONTOLOGY - ANNOTATIONS

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.

Term:hematologic cancer
go back to main search page
Accession:DOID:2531 term browser browse the term
Definition:An organ system cancer located in the hematological system that is characterized by uncontrolled cellular proliferation in blood, bone marrow and lymph nodes. (DO)
Synonyms:exact_synonym: blood cancer;   hematologic malignancies;   hematologic malignancy;   hematological malignancies;   hematological malignancy;   hematological tumors;   hematopoietic and lymphoid system tumor;   hematopoietic cancer;   hematopoietic tumors;   malignant hematopoietic neoplasm
 xref: NCI:C27134
For additional species annotation, visit the Alliance of Genome Resources.



show annotations for term's descendants           Sort by:
 
hematologic cancer term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G KIT KIT proto-oncogene, receptor tyrosine kinase IAGP ClinVar Annotator: match by term: Hematologic cancer
ClinVar Annotator: match by term: Hematological malignancies
ClinVar PMID:7479840 PMID:7513208 PMID:7691885 PMID:8589724 PMID:9657776 More... NCBI chr 4:54,657,957...54,740,715
Ensembl chr 4:54,657,267...54,740,783
JBrowse link
G SLC19A1 solute carrier family 19 member 1 ameliorates IAGP DNA:missense mutation:CDS:p.H27R (human) RGD PMID:21984221 RGD:10449413 NCBI chr21:45,502,517...45,563,025
Ensembl chr21:45,493,572...45,573,365
JBrowse link
G TP53 tumor protein p53 IAGP DNA:missense mutation::p.R337H (human) RGD PMID:28387921 RGD:14995484 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
JBrowse link
acute biphenotypic leukemia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G DOT1L DOT1 like histone lysine methyltransferase treatment IDA RGD PMID:23801631 RGD:9588291 NCBI chr19:2,163,933...2,232,578
Ensembl chr19:2,163,933...2,232,578
JBrowse link
G KMT2A lysine methyltransferase 2A IAGP OMIM NCBI chr11:118,436,492...118,526,832
Ensembl chr11:118,436,456...118,526,832
JBrowse link
G RNF20 ring finger protein 20 disease_progression ISO RGD PMID:23412334 RGD:9831405 NCBI chr 9:101,533,853...101,563,344
Ensembl chr 9:101,533,853...101,563,344
JBrowse link
Acute Erythroleukemia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G DDX41 DEAD-box helicase 41 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30926971 NCBI chr 5:177,511,577...177,516,961
Ensembl chr 5:177,511,577...177,516,961
JBrowse link
G FLT3 fms related receptor tyrosine kinase 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30926971 NCBI chr13:28,003,274...28,100,576
Ensembl chr13:28,003,274...28,100,592
JBrowse link
G GFI1B growth factor independent 1B transcriptional repressor IEP mRNA:increased expression:bone marrow cell: RGD PMID:17156408 RGD:11040507 NCBI chr 9:132,945,531...132,993,434
Ensembl chr 9:132,944,000...132,991,687
JBrowse link
G HOXB9 homeobox B9 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30926971 NCBI chr17:48,621,156...48,626,358
Ensembl chr17:48,621,156...48,626,358
JBrowse link
G KMT2A lysine methyltransferase 2A EXP CTD Direct Evidence: marker/mechanism CTD PMID:30926971 NCBI chr11:118,436,492...118,526,832
Ensembl chr11:118,436,456...118,526,832
JBrowse link
G NPM1 nucleophosmin 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30926971 NCBI chr 5:171,387,116...171,410,900
Ensembl chr 5:171,387,116...171,411,810
JBrowse link
G NUP98 nucleoporin 98 and 96 precursor EXP CTD Direct Evidence: marker/mechanism CTD PMID:30926971 NCBI chr11:3,675,010...3,797,554
Ensembl chr11:3,671,083...3,797,792
JBrowse link
G RB1 RB transcriptional corepressor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30926971 NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
JBrowse link
G TP53 tumor protein p53 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30926971 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
JBrowse link
acute leukemia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ERCC2 ERCC excision repair 2, TFIIH core complex helicase subunit IAGP ClinVar Annotator: match by term: Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified ClinVar PMID:7585650 PMID:9195225 PMID:15982307 PMID:22234153 PMID:23221806 More... NCBI chr19:45,349,837...45,370,573
Ensembl chr19:45,349,837...45,370,918
JBrowse link
acute lymphoblastic leukemia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 susceptibility IAGP
EXP
DNA:snps, haplotype:multiple (human)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:22674224 PMID:22674224 RGD:8657089 NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
JBrowse link
G ABCC2 ATP binding cassette subfamily C member 2 treatment IAGP DNA:SNP:5'UTR:rs717620(human)
DNA:SNPs: :rs717620(human)
RGD PMID:24404132 PMID:25007187 RGD:11080959, RGD:11080979 NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
JBrowse link
G ABCG2 ATP binding cassette subfamily G member 2 (Junior blood group) disease_progression IEP mRNA:increased expression:mononuclear cell: RGD PMID:15521915 PMID:12100141 RGD:11081076, RGD:11081143 NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
JBrowse link
G ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase EXP CTD Direct Evidence: marker/mechanism CTD PMID:11984797 PMID:21898527 NCBI chr 9:130,713,043...130,887,675
Ensembl chr 9:130,713,016...130,887,675
JBrowse link
G ABO ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase susceptibility IAGP RGD PMID:17065136 RGD:11100012 NCBI chr 9:133,250,401...133,275,201
Ensembl chr 9:133,233,278...133,276,024
JBrowse link
G AICDA activation induced cytidine deaminase treatment IEP RGD PMID:19759560 RGD:11039451 NCBI chr12:8,602,170...8,612,859
Ensembl chr12:8,602,155...8,613,242
JBrowse link
G ARID5B AT-rich interaction domain 5B EXP CTD Direct Evidence: marker/mechanism CTD PMID:19684603 PMID:19684604 NCBI chr10:61,901,699...62,096,944
Ensembl chr10:61,901,684...62,096,944
JBrowse link
G ARNT aryl hydrocarbon receptor nuclear translocator EXP CTD Direct Evidence: marker/mechanism CTD PMID:22674224 NCBI chr 1:150,809,713...150,876,599
Ensembl chr 1:150,809,713...150,876,708
JBrowse link
G BAX BCL2 associated X, apoptosis regulator susceptibility IAGP
EXP
CTD Direct Evidence: marker/mechanism OMIM
CTD
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
JBrowse link
G BCL2 BCL2 apoptosis regulator severity IEP mRNA:increased expression:bone marrow (human) RGD PMID:25982455 RGD:11076595 NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
JBrowse link
G BCL2L1 BCL2 like 1 treatment IDA
IEP
mRNA:increased expression:blood, mononuclear cell (human) RGD PMID:12469194 PMID:19020783 RGD:11353852, RGD:11353866 NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
JBrowse link
G BCR BCR activator of RhoGEF and GTPase susceptibility IAGP
EXP
CTD Direct Evidence: marker/mechanism OMIM
CTD
NCBI chr22:23,180,509...23,318,037
Ensembl chr22:23,179,704...23,318,037
JBrowse link
G CASP8 caspase 8 EXP CTD Direct Evidence: therapeutic CTD PMID:22010212 NCBI chr 2:201,233,443...201,287,711
Ensembl chr 2:201,233,443...201,361,836
JBrowse link
G CAST calpastatin IEP protein:increased expresssion:B cell RGD PMID:11264179 RGD:5509822 NCBI chr 5:96,662,037...96,774,683
Ensembl chr 5:96,525,267...96,779,595
JBrowse link
G CCND1 cyclin D1 IEP mRNA:increased expression:bone marrow (human) RGD PMID:22391157 RGD:11352824 NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
JBrowse link
G CD40LG CD40 ligand ISO RGD PMID:9292526 RGD:11352271 NCBI chr  X:136,648,158...136,660,390
Ensembl chr  X:136,648,158...136,660,390
JBrowse link
G CD46 CD46 molecule IEP protein:increased expression:peripheral blood mononuclear cell (human) RGD PMID:16353080 RGD:11352810 NCBI chr 1:207,752,038...207,795,516
Ensembl chr 1:207,752,037...207,795,513
JBrowse link
G CD79B CD79b molecule IEP protein:decreased expression:bone marrow, mononuclear cell (human) RGD PMID:21487112 RGD:11250414 NCBI chr17:63,928,740...63,932,331
Ensembl chr17:63,928,740...63,932,336
JBrowse link
G CD86 CD86 molecule severity IEP protein:increased expression:peripheral blood, bone marrow, mononuclear cell (human) RGD PMID:24283754 RGD:11354967 NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
JBrowse link
G CDK6 cyclin dependent kinase 6 EXP CTD Direct Evidence: marker/mechanism CTD PMID:24736461 NCBI chr 7:92,604,921...92,836,573
Ensembl chr 7:92,604,921...92,836,573
JBrowse link
G CDKN2A cyclin dependent kinase inhibitor 2A disease_progression
susceptibility
no_association
IAGP
EXP
IEP
DNA:deletion: :
CTD Direct Evidence: marker/mechanism
DNA:missense mutations:cds:
CTD
RGD
PMID:20453839 PMID:10090949 PMID:26104880 PMID:25675863 PMID:9204978 RGD:11251764, RGD:11057958, RGD:11252082, RGD:11252081 NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301
JBrowse link
G CEBPE CCAAT enhancer binding protein epsilon EXP CTD Direct Evidence: marker/mechanism CTD PMID:19684604 NCBI chr14:23,117,306...23,119,255
Ensembl chr14:23,117,036...23,120,256
JBrowse link
G CFB complement factor B IAGP DNA:missense mutation:p.R32Q b(human) RGD PMID:6958349 RGD:11041155 NCBI chr 6:31,946,095...31,952,084
Ensembl chr 6:31,945,650...31,952,084
JBrowse link
G CREBBP CREB binding protein disease_progression IAGP DNA:mutations:multiple RGD PMID:25917266 RGD:11060149 NCBI chr16:3,725,054...3,880,713
Ensembl chr16:3,725,054...3,880,713
JBrowse link
G CRLF2 cytokine receptor like factor 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:19838194 NCBI chr  X:1,190,490...1,212,649
NCBI chr  Y:1,190,490...1,212,649
Ensembl chr  X:1,187,549...1,212,723
JBrowse link
G CSF3 colony stimulating factor 3 treatment IDA RGD PMID:9250830 RGD:11039038 NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
JBrowse link
G CSPG4 chondroitin sulfate proteoglycan 4 severity IEP RGD PMID:8562939 RGD:734840 NCBI chr15:75,674,322...75,713,466
Ensembl chr15:75,674,322...75,712,848
JBrowse link
G CYBA cytochrome b-245 alpha chain IEP mRNA:increased expression:peripheral blood mononuclear cell: RGD PMID:19222940 RGD:11040545 NCBI chr16:88,643,289...88,651,053
Ensembl chr16:88,643,275...88,651,083
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 susceptibility
no_association
IAGP DNA:polymorphism:3"UTR:rs4646903(human)
DNA:polymorphism:3'UTR:3801T>C(human)
DNA:polymorphism:cds:2452C>A(p.T461N)(human)
RGD PMID:22964275 PMID:16676594 PMID:23725389 RGD:11352714, RGD:11352728, RGD:11352725 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22674224 NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
JBrowse link
G CYP1B1 cytochrome P450 family 1 subfamily B member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22674224 NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
JBrowse link
G CYP2C8 cytochrome P450 family 2 subfamily C member 8 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22674224 NCBI chr10:95,036,772...95,069,497
Ensembl chr10:95,036,772...95,069,497
JBrowse link
G CYP2D6 cytochrome P450 family 2 subfamily D member 6 susceptibility IAGP DNA:polymorphisms: :
DNA:SNP,deletion:splice junction,exon:1934G>A(human)
RGD PMID:11037802 PMID:19593802 RGD:11352820, RGD:11252111 NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:11774269 NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
JBrowse link
G CYP3A5 cytochrome P450 family 3 subfamily A member 5 disease_progression
susceptibility
IEP
IAGP
DNA:polymorphism: : RGD PMID:19650988 PMID:22215203 RGD:11353796, RGD:11353805 NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,998
JBrowse link
G DHFR dihydrofolate reductase disease_progression IAGP
IEP
DNA:polymorphisms, haplotype:promoter:
DNA:polymorphisms: :-317A>G, 829C>T (human)
RGD PMID:19861437 PMID:12972803 PMID:22969948 PMID:9226157 RGD:11039542, RGD:11039545, RGD:11039544, RGD:11039543 NCBI chr 5:80,626,226...80,654,983
Ensembl chr 5:80,626,226...80,654,983
JBrowse link
G DNMT3A DNA methyltransferase 3 alpha treatment IAGP DNA:mutations:exon, intron:p.R882(human) RGD PMID:25242092 RGD:11041125 NCBI chr 2:25,227,874...25,342,590
Ensembl chr 2:25,227,855...25,342,590
JBrowse link
G DNTT DNA nucleotidylexotransferase IEP protein:increased activity:peripheral blood,bone marrow: RGD PMID:7020399 RGD:8694149 NCBI chr10:96,304,434...96,338,564
Ensembl chr10:96,304,409...96,338,564
JBrowse link
G DPYD dihydropyrimidine dehydrogenase no_association
disease_progression
IAGP DNA:SNP: :85T>C (human)
DNA:SNPs: :2194G>A, 1156G>T (human)
DNA:splice-site mutation:intron:IVS14+1G>A (human)
RGD PMID:26846104 PMID:26846104 PMID:26846104 RGD:11098453, RGD:11098453, RGD:11098453 NCBI chr 1:97,077,743...97,921,059
Ensembl chr 1:97,077,743...97,995,000
JBrowse link
G DUX4 double homeobox 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:27776115 NCBI chr 4:190,173,774...190,185,911
Ensembl chr 4:190,173,774...190,185,942
JBrowse link
G EHMT1 euchromatic histone lysine methyltransferase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:32889036 NCBI chr 9:137,619,005...137,836,127
Ensembl chr 9:137,618,992...137,870,016
JBrowse link
G EHMT2 euchromatic histone lysine methyltransferase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:32889036 NCBI chr 6:31,879,759...31,897,698
Ensembl chr 6:31,879,759...31,897,687
JBrowse link
G ENG endoglin disease_progression IEP RGD PMID:17572488 RGD:11041565 NCBI chr 9:127,815,012...127,854,773
Ensembl chr 9:127,815,013...127,854,658
JBrowse link
G EPHX1 epoxide hydrolase 1 susceptibility
no_association
IAGP
EXP
DNA:missense mutation, haplotype:exon:p.Y113H (human)
CTD Direct Evidence: marker/mechanism
DNA:SNPs:exon:rs1051740, rs2234922 (human)
DNA:polymorphisms:exon
DNA:missense mutation, haplotype:exon:p.H139R (human)
CTD
RGD
PMID:21983886 PMID:21983886 PMID:22200898 PMID:22930568 PMID:19593802 More... RGD:11252110, RGD:11252114, RGD:11252113, RGD:11252111, RGD:11252110 NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
JBrowse link
G ERCC1 ERCC excision repair 1, endonuclease non-catalytic subunit susceptibility IAGP DNA:SNPs: :8092C>A, 19007G>A (human)
DNA:SNPs, haplotypes: :p.R194W, p.R280H, p.R399Q (human)
RGD PMID:16723154 PMID:16435384 RGD:11252160, RGD:11340204 NCBI chr19:45,407,334...45,451,547
Ensembl chr19:45,407,334...45,478,828
JBrowse link
G ERCC2 ERCC excision repair 2, TFIIH core complex helicase subunit no_association IAGP DNA:missense mutations: :p.D312N, p.K751Q (human)
DNA:haplotype
RGD PMID:19101034 PMID:21987080 RGD:11252192, RGD:11340201 NCBI chr19:45,349,837...45,370,573
Ensembl chr19:45,349,837...45,370,918
JBrowse link
G ERG ETS transcription factor ERG EXP CTD Direct Evidence: marker/mechanism CTD PMID:27776115 NCBI chr21:38,367,261...38,661,783
Ensembl chr21:38,380,027...38,661,780
JBrowse link
G ETV6 ETS variant transcription factor 6 IAGP
EXP
ClinVar Annotator: match by term: Acute lymphoid leukemia
CTD Direct Evidence: marker/mechanism
ClinVar
CTD
PMID:17255265 NCBI chr12:11,649,674...11,895,377
Ensembl chr12:11,649,674...11,895,377
JBrowse link
G EZH2 enhancer of zeste 2 polycomb repressive complex 2 subunit ISS OMIM:247640 | OMIM:613065 | OMIM:613067 | OMIM:615545 MouseDO NCBI chr 7:148,807,383...148,884,291
Ensembl chr 7:148,807,257...148,884,321
JBrowse link
G F3 coagulation factor III, tissue factor IEP RGD PMID:8429686 RGD:11340211 NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
JBrowse link
G FAS Fas cell surface death receptor disease_progression IEP protein:increased expression:CD34+ bone marrow cell RGD PMID:10500800 PMID:9711907 RGD:11049148, RGD:11049157 NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
JBrowse link
G FGA fibrinogen alpha chain IEP protein:increased expression:serum (human) RGD PMID:25317080 RGD:11040558 NCBI chr 4:154,583,126...154,590,742
Ensembl chr 4:154,583,128...154,590,745
JBrowse link
G FLT3 fms related receptor tyrosine kinase 3 susceptibility IAGP
EXP
ClinVar Annotator: match by term: Acute lymphocytic leukemia
CTD Direct Evidence: marker/mechanism
ClinVar
CTD
OMIM
PMID:11290608 PMID:11442493 PMID:14604974 PMID:14670924 PMID:15256420 More... NCBI chr13:28,003,274...28,100,576
Ensembl chr13:28,003,274...28,100,592
JBrowse link
G FPGS folylpolyglutamate synthase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25013492 NCBI chr 9:127,802,858...127,814,506
Ensembl chr 9:127,794,597...127,814,327
JBrowse link
G GATA3 GATA binding protein 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:35115686 NCBI chr10:8,045,333...8,075,198
Ensembl chr10:8,045,378...8,075,198
JBrowse link
G GFI1B growth factor independent 1B transcriptional repressor IEP mRNA:increased expression:blood: RGD PMID:19360458 RGD:11040460 NCBI chr 9:132,945,531...132,993,434
Ensembl chr 9:132,944,000...132,991,687
JBrowse link
G GH1 growth hormone 1 treatment IDA RGD PMID:2494952 RGD:11352727 NCBI chr17:63,917,203...63,918,839
Ensembl chr17:63,917,200...63,918,839
JBrowse link
G GNB1 G protein subunit beta 1 susceptibility IAGP
EXP
ClinVar Annotator: match by term: Lymphoblastic leukemia
ClinVar Annotator: match by term: Acute lymphoid leukemia
CTD Direct Evidence: marker/mechanism
OMIM
ClinVar
CTD
PMID:25485910 PMID:25741868 PMID:27108799 PMID:28492532 PMID:32134617 NCBI chr 1:1,785,286...1,891,087
Ensembl chr 1:1,785,285...1,891,117
JBrowse link
G GPI glucose-6-phosphate isomerase IEP RGD PMID:6589021 RGD:11051848 NCBI chr19:34,359,718...34,402,413
Ensembl chr19:34,359,480...34,402,413
JBrowse link
G GPX1 glutathione peroxidase 1 treatment IDA RGD PMID:17317918 PMID:24698347 RGD:11352774, RGD:11352812 NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,176...49,358,353
JBrowse link
G GSR glutathione-disulfide reductase IEP RGD PMID:24191316 RGD:11059506 NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
JBrowse link
G GSTM1 glutathione S-transferase mu 1 disease_progression
susceptibility
no_association
IAGP RGD PMID:10666194 PMID:14607752 PMID:12827651 PMID:15738600 RGD:10450829, RGD:10755410, RGD:10755409, RGD:10755321 NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
JBrowse link
G GSTP1 glutathione S-transferase pi 1 disease_progression
no_association
susceptibility
IAGP DNA:haplotype:cds:
DNA:polymorphism: :1578 a>G(human)
DNA:transition mutation:exon:
RGD PMID:10666194 PMID:23979883 PMID:15738600 RGD:10450829, RGD:10755417, RGD:10755321 NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
JBrowse link
G GSTT1 glutathione S-transferase theta 1 disease_progression
susceptibility
IAGP RGD PMID:10666194 PMID:14607752 RGD:10450829, RGD:10755410
G H1-2 H1.2 linker histone, cluster member susceptibility IAGP DNA:SNP, haplotype:enhancer: (rs807212) (human) RGD PMID:19806355 RGD:10755490 NCBI chr 6:26,055,740...26,056,470
Ensembl chr 6:26,055,740...26,056,470
JBrowse link
G HCK HCK proto-oncogene, Src family tyrosine kinase EXP CTD Direct Evidence: marker/mechanism CTD PMID:17344919 NCBI chr20:32,052,242...32,101,856
Ensembl chr20:32,052,197...32,101,856
JBrowse link
G HDAC1 histone deacetylase 1 disease_progression IEP mRNA:increased expression:bone marrow,blood: RGD PMID:23948281 RGD:9681454 NCBI chr 1:32,292,083...32,333,626
Ensembl chr 1:32,292,083...32,333,635
JBrowse link
G HDAC2 histone deacetylase 2 disease_progression IEP mRNA:increased expression:bone marrow,blood: RGD PMID:23948281 RGD:9681454 NCBI chr 6:113,933,028...113,971,148
Ensembl chr 6:113,933,028...114,011,308
JBrowse link
G HDAC4 histone deacetylase 4 treatment IEP RGD PMID:23948281 RGD:9681454 NCBI chr 2:239,048,168...239,401,649
Ensembl chr 2:239,048,168...239,401,654
JBrowse link
G HFE homeostatic iron regulator no_association IAGP DNA:missense mutation:cds:p.H63D (human)
DNA:missense mutation: :p.H63D (human)
DNA:missense mutation:cds:p.C282Y (human)
RGD PMID:10627122 PMID:17107905 PMID:10627122 RGD:10755557, RGD:10755558, RGD:10755557 NCBI chr 6:26,087,429...26,098,343
Ensembl chr 6:26,087,281...26,098,343
JBrowse link
G HK1 hexokinase 1 IDA protein:decreased activity:platelet RGD PMID:21921332 RGD:11353881 NCBI chr10:69,270,000...69,401,882
Ensembl chr10:69,269,984...69,401,884
JBrowse link
G HLA-DQA1 major histocompatibility complex, class II, DQ alpha 1 IAGP DNA:polymorphisms, haplotype:cds:HLA-DQA1*01 (human) RGD PMID:9744491 RGD:11041762 NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
JBrowse link
G HLA-DQB1 major histocompatibility complex, class II, DQ beta 1 IAGP DNA:polymorphisms, haplotypes:cds:multiple
DNA:polymorphisms, haplotype:cds:HLA-DQB1*0501 (human)
RGD PMID:22434102 PMID:9744491 RGD:11041749, RGD:11041762 NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
JBrowse link
G HLF HLF transcription factor, PAR bZIP family member EXP CTD Direct Evidence: marker/mechanism CTD PMID:26214592 NCBI chr17:55,264,960...55,325,187
Ensembl chr17:55,264,960...55,325,187
JBrowse link
G HOXD4 homeobox D4 IAGP
EXP
ClinVar Annotator: match by term: Leukemia, acute lymphoblastic, susceptibility to
CTD Direct Evidence: marker/mechanism
ClinVar
CTD
PMID:15776434 NCBI chr 2:176,151,550...176,153,226
Ensembl chr 2:176,151,550...176,153,226
JBrowse link
G IDH1 isocitrate dehydrogenase (NADP(+)) 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22674224 NCBI chr 2:208,236,227...208,255,071
Ensembl chr 2:208,236,229...208,266,074
JBrowse link
G IFNG interferon gamma susceptibility IAGP DNA:SNP: :rs2069727(human) RGD PMID:21067287 RGD:10755691 NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
JBrowse link
G IKZF1 IKAROS family zinc finger 1 IAGP
EXP
ClinVar Annotator: match by term: LEUKEMIA, ACUTE LYMPHOCYTIC, SUSCEPTIBILITY TO, 2
DNA:SNPs: (human)
ClinVar Annotator: match by term: Acute lymphoid leukemia
CTD Direct Evidence: marker/mechanism
ClinVar
CTD
RGD
PMID:19684604 PMID:24786325 RGD:151347631 NCBI chr 7:50,303,455...50,405,101
Ensembl chr 7:50,304,068...50,405,101
JBrowse link
G IKZF2 IKAROS family zinc finger 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:23334668 NCBI chr 2:212,999,698...213,152,456
Ensembl chr 2:212,999,691...213,152,427
JBrowse link
G IKZF3 IKAROS family zinc finger 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:23334668 NCBI chr17:39,757,715...39,864,312
Ensembl chr17:39,757,718...39,864,312
JBrowse link
G IL10 interleukin 10 treatment IEP protein:decreased expression:blood RGD PMID:21653647 PMID:15860861 RGD:11049158, RGD:11049169 NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
JBrowse link
G IRF4 interferon regulatory factor 4 IAGP DNA:SNP:intron:rs12203592 (human) RGD PMID:19897031 RGD:11526162 NCBI chr 6:391,752...411,443
Ensembl chr 6:391,739...411,443
JBrowse link
G ITPA inosine triphosphatase treatment
no_association
IAGP DNA:SNPs:exon:94C>A, 138G>A (human)
DNA:SNP:intron
RGD PMID:22009189 PMID:22009189 RGD:10766474, RGD:10766474 NCBI chr20:3,204,065...3,227,449
Ensembl chr20:3,208,868...3,223,870
JBrowse link
G KDM2B lysine demethylase 2B IEP mRNA:increased expression:bone marrow (human) RGD PMID:21310926 RGD:9588255 NCBI chr12:121,408,461...121,582,279
Ensembl chr12:121,429,096...121,581,023
JBrowse link
G KDM3B lysine demethylase 3B IEP protein:increased expression:bone marrow, mononuclear cell (human) RGD PMID:22615488 RGD:9586728 NCBI chr 5:138,352,685...138,437,027
Ensembl chr 5:138,352,685...138,437,028
JBrowse link
G KDM6A lysine demethylase 6A severity IAGP DNA:mutations:cds:multiple (human) RGD PMID:22377896 RGD:9684944 NCBI chr  X:44,873,188...45,112,779
Ensembl chr  X:44,873,188...45,112,779
JBrowse link
G KMT2A lysine methyltransferase 2A EXP CTD Direct Evidence: marker/mechanism CTD PMID:24736461 PMID:25730765 NCBI chr11:118,436,492...118,526,832
Ensembl chr11:118,436,456...118,526,832
JBrowse link
G KRAS KRAS proto-oncogene, GTPase disease_progression IAGP RGD PMID:17910045 PMID:25917266 RGD:11060148, RGD:11060149 NCBI chr12:25,205,246...25,250,929
Ensembl chr12:25,205,246...25,250,936
JBrowse link
G LMO2 LIM domain only 2 ISS OMIM:247640 | OMIM:613065 | OMIM:613067 | OMIM:615545 MouseDO NCBI chr11:33,858,576...33,892,076
Ensembl chr11:33,858,576...33,892,076
JBrowse link
G MEFV MEFV innate immuity regulator, pyrin susceptibility IAGP DNA:polymorphisms:cds:p.E148Q,M680I(human) RGD PMID:22942567 RGD:11531121 NCBI chr16:3,242,027...3,256,633
Ensembl chr16:3,242,027...3,256,633
JBrowse link
G MTHFR methylenetetrahydrofolate reductase disease_progression
treatment
IAGP
EXP
DNA:missense mutation:cds:677C>T (p.A222V) (rs1801133) (human)
CTD Direct Evidence: marker/mechanism
DNA:missense mutation:cds:677C>T (human)
CTD
RGD
PMID:16706930 PMID:19923983 PMID:21644011 RGD:10449398, RGD:10449407 NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
JBrowse link
G MTR 5-methyltetrahydrofolate-homocysteine methyltransferase disease_progression
susceptibility
no_association
IAGP DNA:SNP::rs10925235(human)
DNA:polymorphism: :66A>G(human)
DNA:polymorphism: :2756A>G(human)
RGD PMID:26605150 PMID:21618417 PMID:15159311 PMID:22453148 RGD:11531136, RGD:11531141, RGD:11531140, RGD:11531137 NCBI chr 1:236,795,281...236,903,981
Ensembl chr 1:236,795,260...236,921,278
JBrowse link
G MTRR 5-methyltetrahydrofolate-homocysteine methyltransferase reductase susceptibility IAGP
EXP
DNA:haplotype:cds:
CTD Direct Evidence: marker/mechanism
DNA:SNP: :rs3776455(human)
CTD
RGD
PMID:17136115 PMID:17136115 PMID:23940529 RGD:11531133, RGD:11531135 NCBI chr 5:7,850,859...7,901,113
Ensembl chr 5:7,851,186...7,906,025
JBrowse link
G MYC MYC proto-oncogene, bHLH transcription factor disease_progression IEP RGD PMID:25784651 RGD:11532748 NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
JBrowse link
G NAT2 N-acetyltransferase 2 susceptibility
no_association
IAGP
EXP
DNA:polymorphisms: :
CTD Direct Evidence: marker/mechanism
DNA:polymorphisms,haplotype: :
CTD
RGD
PMID:22200898 PMID:25804798 PMID:22215203 PMID:21888617 RGD:11532767, RGD:11353805, RGD:11532769 NCBI chr 8:18,386,301...18,401,218
Ensembl chr 8:18,391,282...18,401,218
JBrowse link
G NBN nibrin susceptibility IAGP
EXP
ClinVar Annotator: match by term: Acute lymphoid leukemia
ClinVar Annotator: match by term: Leukemia, acute lymphoblastic, susceptibility to
CTD Direct Evidence: marker/mechanism
OMIM
ClinVar
CTD
PMID:9590180 PMID:11325820 PMID:14559852 PMID:15338273 PMID:16415040 More... NCBI chr 8:89,933,331...89,984,667
Ensembl chr 8:89,933,331...90,003,228
JBrowse link
G NOS3 nitric oxide synthase 3 susceptibility
disease_progression
IAGP DNA:SNP: :rs3918186(human)
DNA:polymorphism, haplotype:cds,intron:P.E298D,-786T>C(human)
RGD PMID:23922896 PMID:20510681 RGD:11533639, RGD:11533646 NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
JBrowse link
G NOTCH3 notch receptor 3 ISS OMIM:247640 | OMIM:613065 | OMIM:613067 | OMIM:615545 MouseDO NCBI chr19:15,159,038...15,200,995
Ensembl chr19:15,159,038...15,200,995
JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 IAGP
EXP
DNA:mutation: :609C>T (human)
CTD Direct Evidence: marker/mechanism
DNA:missense mutations: :p.R139W (465C>T), p.P187S (609C>T) (human)
CTD
RGD
PMID:11774269 PMID:17332311 PMID:18444911 PMID:11774269 RGD:10769347, RGD:10769359 NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
JBrowse link
G NRAS NRAS proto-oncogene, GTPase disease_progression IAGP DNA:missense mutation:cds: RGD PMID:25204082 RGD:11535045 NCBI chr 1:114,704,469...114,716,771
Ensembl chr 1:114,704,469...114,716,771
JBrowse link
G NSD2 nuclear receptor binding SET domain protein 2 EXP CTD Direct Evidence: therapeutic CTD PMID:24076604 NCBI chr 4:1,871,393...1,982,192
Ensembl chr 4:1,871,393...1,982,207
JBrowse link
G NT5C2 5'-nucleotidase, cytosolic II EXP CTD Direct Evidence: marker/mechanism CTD PMID:23377183 NCBI chr10:103,088,017...103,193,272
Ensembl chr10:103,087,185...103,277,605
JBrowse link
G NUP214 nucleoporin 214 susceptibility IAGP
EXP
CTD Direct Evidence: marker/mechanism OMIM
CTD
NCBI chr 9:131,125,586...131,234,663
Ensembl chr 9:131,125,573...131,234,663
JBrowse link
G P2RY8 P2Y receptor family member 8 EXP CTD Direct Evidence: marker/mechanism CTD PMID:19838194 NCBI chr  X:1,462,581...1,537,185
NCBI chr  Y:1,462,581...1,537,185
Ensembl chr  X:1,462,581...1,537,185
JBrowse link
G PAG1 phosphoprotein membrane anchor with glycosphingolipid microdomains 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:23334668 NCBI chr 8:80,967,810...81,112,068
Ensembl chr 8:80,967,810...81,112,068
JBrowse link
G PAX5 paired box 5 susceptibility IAGP
EXP
ClinVar Annotator: match by term: Leukemia, acute lymphoblastic, susceptibility to, 3
CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Acute lymphoid leukemia
OMIM
ClinVar
CTD
PMID:24013638 PMID:24728327 PMID:25741868 PMID:26214592 NCBI chr 9:36,833,269...37,034,268
Ensembl chr 9:36,833,269...37,034,268
JBrowse link
G PON1 paraoxonase 1 susceptibility IAGP DNA:missense mutations:cds:p.L55M (rs854560), p.Q192R (rs662) (human) RGD PMID:22976839 RGD:11552580 NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
JBrowse link
G PRAME PRAME nuclear receptor transcriptional regulator severity IEP mRNA:increased expression:blood (human) RGD PMID:27275197 RGD:11535025 NCBI chr22:22,547,701...22,559,265
Ensembl chr22:22,547,701...22,559,361
JBrowse link
G PRDM14 PR/SET domain 14 EXP CTD Direct Evidence: marker/mechanism CTD PMID:19043588 NCBI chr 8:70,051,651...70,071,252
Ensembl chr 8:70,051,651...70,071,693
JBrowse link
G PTEN phosphatase and tensin homolog ISS OMIM:247640 | OMIM:613065 | OMIM:613067 | OMIM:615545 MouseDO NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
JBrowse link
G RB1 RB transcriptional corepressor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:23334668 NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
JBrowse link
G RUNX1 RUNX family transcription factor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17255265 NCBI chr21:34,787,801...35,049,302
Ensembl chr21:34,787,801...36,004,667
JBrowse link
G SLC19A1 solute carrier family 19 member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17255265 NCBI chr21:45,502,517...45,563,025
Ensembl chr21:45,493,572...45,573,365
JBrowse link
G SNRPE small nuclear ribonucleoprotein polypeptide E severity IEP mRNA:decreased expression:bone marrow, blood, mononuclear cell (human) RGD PMID:23915977 RGD:10768836 NCBI chr 1:203,861,599...203,871,152
Ensembl chr 1:203,861,599...203,871,152
JBrowse link
G TAL1 TAL bHLH transcription factor 1, erythroid differentiation factor susceptibility IAGP
EXP
CTD Direct Evidence: marker/mechanism OMIM
CTD
NCBI chr 1:47,216,290...47,232,335
Ensembl chr 1:47,216,290...47,232,225
JBrowse link
G TAL2 TAL bHLH transcription factor 2 susceptibility IAGP
EXP
CTD Direct Evidence: marker/mechanism OMIM
CTD
NCBI chr 9:105,662,457...105,663,124
Ensembl chr 9:105,662,457...105,663,124
JBrowse link
G TCF3 transcription factor 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26214592 NCBI chr19:1,609,292...1,652,615
Ensembl chr19:1,609,290...1,652,615
JBrowse link
G TCN2 transcobalamin 2 IEP protein:altered activity:plasma: RGD PMID:8754152 RGD:11059889 NCBI chr22:30,607,174...30,627,271
Ensembl chr22:30,607,003...30,627,271
JBrowse link
G TERT telomerase reverse transcriptase IAGP
IEP
DNA:SNPs:promoter, introns:g.1296486C>T, g.12866516A>C, g.1279790G>A (rs2735940, rs2736100, rs10069690) (human) RGD PMID:23066086 PMID:15621763 RGD:11038654, RGD:11038667 NCBI chr 5:1,253,167...1,295,068
Ensembl chr 5:1,253,147...1,295,068
JBrowse link
G TM9SF2 transmembrane 9 superfamily member 2 IEP mRNA:increased expression:bone marrow, mononuclear cells (human) RGD PMID:12730115 RGD:2317244 NCBI chr13:99,501,472...99,564,048
Ensembl chr13:99,446,311...99,564,048
JBrowse link
G TP53 tumor protein p53 EXP CTD Direct Evidence: marker/mechanism CTD PMID:23334668 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
JBrowse link
G TPMT thiopurine S-methyltransferase treatment
no_association
IAGP DNA:SNPs:multiple
DNA:SNPs:introns:12356C>T, 16638C>T, 26354G>T (rs4449636, rs2518463, rs2842949) (human)
DNA:SNPs:exon:374C>T, 719A>G (rs2842934, rs1142345) (human)
DNA:SNPs: :multiple
RGD PMID:17164697 PMID:22009189 PMID:22009189 PMID:24499706 RGD:11038720, RGD:10766474, RGD:10766474, RGD:11038723 NCBI chr 6:18,128,311...18,155,169
Ensembl chr 6:18,128,311...18,155,077
JBrowse link
G TYMS thymidylate synthetase treatment IAGP DNA:repeats: : rs347430033(human) RGD PMID:25007187 RGD:11080979 NCBI chr18:657,653...673,578
Ensembl chr18:657,653...673,578
JBrowse link
G VPREB1 V-set pre-B cell surrogate light chain 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26214592 NCBI chr22:22,244,786...22,245,515
Ensembl chr22:22,244,780...22,245,515
JBrowse link
G XRCC1 X-ray repair cross complementing 1 susceptibility
no_association
IAGP
EXP
DNA:missense mutation, haplotype: :p.R399Q (human)
CTD Direct Evidence: marker/mechanism
DNA:missense mutation: :p.R399Q (human)
DNA:missense mutation: :p.R194W (human)
CTD
RGD
PMID:21983886 PMID:21983886 PMID:19101034 PMID:19101034 RGD:11252110, RGD:11252192, RGD:11252192 NCBI chr19:43,543,311...43,575,527
Ensembl chr19:43,543,311...43,580,473
JBrowse link
Acute Lymphoblastic Leukemia, with Lymphomatous Features term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase IAGP ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features ClinVar PMID:10988075 PMID:11423618 PMID:11853795 PMID:11861307 PMID:11964322 More... NCBI chr 9:130,713,043...130,887,675
Ensembl chr 9:130,713,016...130,887,675
JBrowse link
G CRLF2 cytokine receptor like factor 2 IAGP ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features ClinVar PMID:19907440 PMID:19965641 PMID:20018760 PMID:22368272 NCBI chr  X:1,190,490...1,212,649
NCBI chr  Y:1,190,490...1,212,649
Ensembl chr  X:1,187,549...1,212,723
JBrowse link
G CYP2B6 cytochrome P450 family 2 subfamily B member 6 susceptibility IAGP DNA:polymorphism:G15631T RGD PMID:19144407 RGD:6480472 NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
JBrowse link
G FGFR1 fibroblast growth factor receptor 1 IAGP ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features ClinVar PMID:25705862 PMID:26619011 PMID:26942290 PMID:33448156 NCBI chr 8:38,411,143...38,468,635
Ensembl chr 8:38,400,215...38,468,834
JBrowse link
G IL7R interleukin 7 receptor IAGP ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features ClinVar PMID:22897847 PMID:22955920 NCBI chr 5:35,856,891...35,879,603
Ensembl chr 5:35,852,695...35,879,603
JBrowse link
G INSL6 insulin like 6 IAGP ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features ClinVar PMID:18805579 PMID:19470474 PMID:20585391 PMID:22368270 PMID:22955920 NCBI chr 9:4,991,976...5,185,639
Ensembl chr 9:5,123,880...5,185,647
JBrowse link
G JAK1 Janus kinase 1 IAGP ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features ClinVar PMID:16239216 PMID:19139102 PMID:19470474 PMID:19838194 PMID:20167706 More... NCBI chr 1:64,833,229...65,067,746
Ensembl chr 1:64,833,229...65,067,754
JBrowse link
G JAK2 Janus kinase 2 IAGP ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features ClinVar PMID:18805579 PMID:19470474 PMID:20585391 PMID:22368270 PMID:22955920 NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
JBrowse link
G JAK3 Janus kinase 3 IAGP ClinVar Annotator: match by term: Lymphoblastic leukemia, acute, with lymphomatous features ClinVar PMID:10982185 PMID:16843266 PMID:18270328 PMID:20132407 PMID:20372971 More... NCBI chr19:17,824,782...17,847,982
Ensembl chr19:17,824,780...17,848,071
JBrowse link
acute megakaryocytic leukemia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCG2 ATP binding cassette subfamily G member 2 (Junior blood group) IEP RGD PMID:21640380 RGD:11081147 NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
JBrowse link
G BIRC5 baculoviral IAP repeat containing 5 EXP CTD Direct Evidence: therapeutic CTD PMID:16166298 NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
JBrowse link
G CORO7 coronin 7 IAGP ClinVar Annotator: match by term: Acute megakaryoblastic leukemia ClinVar NCBI chr16:4,354,542...4,416,596
Ensembl chr16:4,354,542...4,425,705
JBrowse link
G CORO7-PAM16 CORO7-PAM16 readthrough IAGP ClinVar Annotator: match by term: Acute megakaryoblastic leukemia ClinVar NCBI chr16:4,340,251...4,416,596
Ensembl chr16:4,340,251...4,420,494
JBrowse link
G EZH2 enhancer of zeste 2 polycomb repressive complex 2 subunit IAGP associated with Down Syndrome;DNA:mutations:multiple (human) RGD PMID:24056718 RGD:10450890 NCBI chr 7:148,807,383...148,884,291
Ensembl chr 7:148,807,257...148,884,321
JBrowse link
G GATA1 GATA binding protein 1 IAGP ClinVar Annotator: match by term: Acute megakaryocytic leukemia ClinVar PMID:15070711 PMID:16783379 PMID:22706301 PMID:23704091 PMID:24453067 More... NCBI chr  X:48,786,590...48,794,311
Ensembl chr  X:48,786,540...48,794,311
JBrowse link
G GFI1B growth factor independent 1B transcriptional repressor IEP mRNA:increased expression:bone marrow cell: RGD PMID:17156408 RGD:11040507 NCBI chr 9:132,945,531...132,993,434
Ensembl chr 9:132,944,000...132,991,687
JBrowse link
G JAK3 Janus kinase 3 IMP
IAGP
ClinVar Annotator: match by term: Acute megakaryoblastic leukemia ClinVar
RGD
PMID:10982185 PMID:16843266 PMID:18270328 PMID:18397343 PMID:20132407 More... RGD:11531113 NCBI chr19:17,824,782...17,847,982
Ensembl chr19:17,824,780...17,848,071
JBrowse link
G MDGA1 MAM domain containing glycosylphosphatidylinositol anchor 1 IAGP ClinVar Annotator: match by term: Acute megakaryoblastic leukemia ClinVar NCBI chr 6:37,630,679...37,697,883
Ensembl chr 6:37,630,679...37,699,306
JBrowse link
G MRTFA myocardin related transcription factor A IAGP RGD PMID:11431691 RGD:1599948 NCBI chr22:40,410,289...40,636,719
Ensembl chr22:40,410,281...40,636,719
JBrowse link
G MT-ND6 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 IAGP ClinVar Annotator: match by term: Acute megakaryoblastic leukemia ClinVar NCBI chr MT:14,149...14,673
Ensembl chr MT:14,149...14,673
JBrowse link
G PCF11 PCF11 cleavage and polyadenylation factor subunit IAGP ClinVar Annotator: match by term: Acute megakaryoblastic leukemia ClinVar NCBI chr11:83,157,131...83,187,451
Ensembl chr11:83,156,988...83,187,451
JBrowse link
G PRAME PRAME nuclear receptor transcriptional regulator IEP associated with Down Syndrome;mRNA:increased expression:mononuclear cell (human) RGD PMID:15180862 RGD:11535064 NCBI chr22:22,547,701...22,559,265
Ensembl chr22:22,547,701...22,559,361
JBrowse link
G PTEN phosphatase and tensin homolog IAGP ClinVar Annotator: match by term: Acute megakaryoblastic leukemia ClinVar PMID:10848731 PMID:17941496 PMID:20600018 PMID:21194675 PMID:21343951 More... NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
JBrowse link
G RASAL3 RAS protein activator like 3 IAGP ClinVar Annotator: match by term: Acute megakaryoblastic leukemia ClinVar NCBI chr19:15,451,624...15,464,544
Ensembl chr19:15,451,624...15,464,544
JBrowse link
G RUNX1 RUNX family transcription factor 1 onset ISO RGD PMID:15856017 RGD:11251701 NCBI chr21:35,372,507...35,580,764
Ensembl chr21:34,787,801...36,004,667
JBrowse link
G RUNX1 RUNX family transcription factor 1 onset ISO RGD PMID:15856017 RGD:11251701 NCBI chr21:34,787,801...35,049,302
Ensembl chr21:34,787,801...36,004,667
JBrowse link
G SLC9A2 solute carrier family 9 member A2 IAGP ClinVar Annotator: match by term: Acute megakaryoblastic leukemia ClinVar NCBI chr 2:102,619,553...102,711,355
Ensembl chr 2:102,619,553...102,711,355
JBrowse link
G SNCB synuclein beta IEP RGD PMID:21264917 RGD:6478703 NCBI chr 5:176,620,082...176,630,534
Ensembl chr 5:176,620,082...176,630,556
JBrowse link
G TP53 tumor protein p53 IAGP ClinVar Annotator: match by term: Acute megakaryocytic leukemia ClinVar PMID:11370630 PMID:20522432 PMID:28492532 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
JBrowse link
acute monocytic leukemia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G DNMT3A DNA methyltransferase 3 alpha EXP CTD Direct Evidence: marker/mechanism CTD PMID:21399634 NCBI chr 2:25,227,874...25,342,590
Ensembl chr 2:25,227,855...25,342,590
JBrowse link
G KMT2A lysine methyltransferase 2A EXP CTD Direct Evidence: marker/mechanism CTD PMID:8282816 NCBI chr11:118,436,492...118,526,832
Ensembl chr11:118,436,456...118,526,832
JBrowse link
G MLLT10 MLLT10 histone lysine methyltransferase DOT1L cofactor IAGP RGD PMID:7662954 RGD:1598771 NCBI chr10:21,533,756...21,743,630
Ensembl chr10:21,524,646...21,743,630
JBrowse link
G NF1 neurofibromin 1 IAGP ClinVar Annotator: match by term: Acute monocytic leukemia ClinVar PMID:25741868 PMID:28492532 NCBI chr17:31,094,927...31,377,677
Ensembl chr17:31,094,927...31,382,116
JBrowse link
G STK11 serine/threonine kinase 11 IAGP ClinVar Annotator: match by term: Acute monocytic leukemia ClinVar PMID:25117502 PMID:25741868 PMID:25980754 PMID:26467025 PMID:28492532 NCBI chr19:1,205,778...1,228,431
Ensembl chr19:1,177,558...1,228,431
JBrowse link
acute myeloid leukemia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCC3 ATP binding cassette subfamily C member 3 disease_progression IEP RGD PMID:26512967 RGD:11081145 NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
JBrowse link
G ABCG2 ATP binding cassette subfamily G member 2 (Junior blood group) disease_progression
treatment
IEP RGD PMID:26512967 PMID:12145683 RGD:11081145, RGD:11099971 NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
JBrowse link
G ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase IAGP DNA:translocation: : RGD PMID:12161353 RGD:10450603 NCBI chr 9:130,713,043...130,887,675
Ensembl chr 9:130,713,016...130,887,675
JBrowse link
G ACSL6 acyl-CoA synthetase long chain family member 6 IAGP DNA:translocation: :t(5;12)(q31;p13) (human) RGD PMID:10502316 RGD:1599805 NCBI chr 5:131,949,973...132,012,068
Ensembl chr 5:131,949,973...132,012,243
JBrowse link
G ADCY7 adenylate cyclase 7 EXP CTD Direct Evidence: marker/mechanism CTD PMID:18206229 NCBI chr16:50,244,699...50,318,135
Ensembl chr16:50,246,137...50,318,135
JBrowse link
G AGRN agrin EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr 1:1,020,120...1,056,116
Ensembl chr 1:1,020,120...1,056,118
JBrowse link
G ANAPC2 anaphase promoting complex subunit 2 IEP mRNA:increased expression:blood (human) RGD PMID:26046517 RGD:11067888 NCBI chr 9:137,174,784...137,188,560
Ensembl chr 9:137,174,784...137,188,560
JBrowse link
G ANXA2 annexin A2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr15:60,347,151...60,397,986
Ensembl chr15:60,347,134...60,402,883
JBrowse link
G ANXA4 annexin A4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr 2:69,643,808...69,827,112
Ensembl chr 2:69,644,425...69,827,112
JBrowse link
G ANXA5 annexin A5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr 4:121,667,946...121,696,980
Ensembl chr 4:121,667,946...121,696,995
JBrowse link
G ANXA6 annexin A6 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr 5:151,100,706...151,157,779
Ensembl chr 5:151,100,706...151,157,785
JBrowse link
G AQP9 aquaporin 9 EXP CTD Direct Evidence: therapeutic CTD PMID:16968895 NCBI chr15:58,138,169...58,185,911
Ensembl chr15:58,138,169...58,185,911
JBrowse link
G ARID4A AT-rich interaction domain 4A ISS OMIM:601626 MouseDO NCBI chr14:58,298,555...58,373,876
Ensembl chr14:58,298,504...58,373,887
JBrowse link
G ASMTL acetylserotonin O-methyltransferase like EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr  X:1,403,139...1,453,756
NCBI chr  Y:1,403,139...1,453,756
Ensembl chr  X:1,403,139...1,453,762
JBrowse link
G ASXL1 ASXL transcriptional regulator 1 disease_progression IAGP
ISS
DNA:mutations:exon:
OMIM:601626
MouseDO
RGD
PMID:20693432 RGD:11038706 NCBI chr20:32,358,331...32,439,319
Ensembl chr20:32,358,330...32,439,319
JBrowse link
G ASXL2 ASXL transcriptional regulator 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:27798625 NCBI chr 2:25,733,753...25,878,487
Ensembl chr 2:25,733,753...25,878,487
JBrowse link
G ATG2B autophagy related 2B IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar NCBI chr14:96,279,195...96,363,341
Ensembl chr14:96,279,195...96,363,341
JBrowse link
G ATP1B1 ATPase Na+/K+ transporting subunit beta 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr 1:169,106,690...169,132,719
Ensembl chr 1:169,105,697...169,310,992
JBrowse link
G BAALC BAALC binder of MAP3K1 and KLF4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:19822134 NCBI chr 8:103,140,725...103,230,305
Ensembl chr 8:103,140,713...103,230,305
JBrowse link
G BACH2 BTB domain and CNC homolog 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21441929 NCBI chr 6:89,926,528...90,296,843
Ensembl chr 6:89,926,528...90,296,843
JBrowse link
G BCL2 BCL2 apoptosis regulator susceptibility
severity
IAGP
EXP
IEP
DNA:snp:promoter:g.-938C>A (human)
CTD Direct Evidence: marker/mechanism
DNA:snp:exon:c.+21A>G (rs1801018) (human)
ratio with Flt3, Kit;mRNA:decreased expression:mononuclear cell (human)
CTD
RGD
PMID:23906301 PMID:25957891 PMID:19520430 PMID:25216797 RGD:11526107, RGD:11526111, RGD:11526109 NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
JBrowse link
G BCL2L1 BCL2 like 1 severity IEP mRNA:increased expression:peripheral blood, bone marrow, blast cell (human) RGD PMID:11410409 RGD:11353851 NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
JBrowse link
G BDKRB1 bradykinin receptor B1 IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar NCBI chr14:96,256,210...96,264,763
Ensembl chr14:96,256,210...96,268,967
JBrowse link
G BDKRB2 bradykinin receptor B2 IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar NCBI chr14:96,204,839...96,244,164
Ensembl chr14:96,204,679...96,244,166
JBrowse link
G BMI1 BMI1 proto-oncogene, polycomb ring finger IDA RGD PMID:16105758 RGD:1580059 NCBI chr10:22,321,099...22,331,484
Ensembl chr10:22,321,099...22,331,484
JBrowse link
G BRD4 bromodomain containing 4 ISO RGD PMID:21814200 RGD:9586350 NCBI chr19:15,235,519...15,332,539
Ensembl chr19:15,235,519...15,332,545
JBrowse link
G BRD7 bromodomain containing 7 susceptibility IEP
IAGP
mRNA:increased expression:bone marrow:
DNA:haplotype:cds:737A>G,495C>T(human)
RGD PMID:18772500 PMID:18772500 RGD:9586443, RGD:9586443 NCBI chr16:50,315,957...50,368,988
Ensembl chr16:50,313,487...50,368,988
JBrowse link
G BTG1 BTG anti-proliferation factor 1 disease_progression IEP RGD PMID:15449376 RGD:1549463 NCBI chr12:92,140,278...92,145,846
Ensembl chr12:92,140,278...92,145,846
JBrowse link
G C14orf132 chromosome 14 open reading frame 132 IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar NCBI chr14:96,039,362...96,093,971
Ensembl chr14:96,039,362...96,093,971
JBrowse link
G CALR calreticulin IEP mRNA:increased expression:peripheral blood (human) RGD PMID:26640226 RGD:11076986 NCBI chr19:12,938,609...12,944,489
Ensembl chr19:12,938,578...12,944,489
JBrowse link
G CAPG capping actin protein, gelsolin like EXP CTD Direct Evidence: marker/mechanism CTD PMID:18206229 NCBI chr 2:85,391,602...85,419,540
Ensembl chr 2:85,394,753...85,418,432
JBrowse link
G CAPN2 calpain 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr 1:223,701,597...223,776,018
Ensembl chr 1:223,701,593...223,776,018
JBrowse link
G CASP7 caspase 7 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
JBrowse link
G CBFB core-binding factor subunit beta IAGP
EXP
ClinVar Annotator: match by term: Acute myeloid leukemia
CTD Direct Evidence: marker/mechanism
OMIM
ClinVar
CTD
PMID:18206229 PMID:25741868 PMID:27798625 NCBI chr16:67,029,149...67,101,058
Ensembl chr16:67,028,984...67,101,058
JBrowse link
G CBL Cbl proto-oncogene disease_progression IAGP associated with Myelodysplastic Syndromes;DNA:mutations:exons: RGD PMID:22131879 RGD:11038796 NCBI chr11:119,206,339...119,308,149
Ensembl chr11:119,206,298...119,313,926
JBrowse link
G CCL2 C-C motif chemokine ligand 2 treatment ISO
IEP
protein:increased expression:plasma (human) RGD PMID:25382729 PMID:17822317 RGD:11528532, RGD:11528537 NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
JBrowse link
G CCNA1 cyclin A1 IEP protein:increased expression:leukocyte (human) RGD PMID:10068680 RGD:2316304 NCBI chr13:36,431,517...36,442,870
Ensembl chr13:36,431,520...36,442,870
JBrowse link
G CCND1 cyclin D1 treatment IEP
IDA
mRNA:increased expression:bone marrow (human)
human tumor in a mouse model
RGD PMID:22391157 PMID:21928377 RGD:11352824, RGD:11353789 NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
JBrowse link
G CCND2 cyclin D2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:27798625 NCBI chr12:4,273,762...4,305,353
Ensembl chr12:4,269,771...4,305,353
JBrowse link
G CD33 CD33 molecule EXP CTD Direct Evidence: marker/mechanism CTD PMID:12921496 NCBI chr19:51,211,076...51,240,016
Ensembl chr19:51,225,064...51,243,860
JBrowse link
G CD44 CD44 molecule (Indian blood group) EXP CTD Direct Evidence: marker/mechanism CTD PMID:23098472 NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
JBrowse link
G CD86 CD86 molecule severity ISO
IEP
protein:increased expression:mononuclear cell of bone marrow (human) RGD PMID:19197726 PMID:16115907 RGD:4892295, RGD:11354960 NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
JBrowse link
G CD9 CD9 molecule EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr12:6,199,946...6,238,266
Ensembl chr12:6,199,715...6,238,271
JBrowse link
G CDH1 cadherin 1 disease_progression IAGP DNA:hypermethylation:promoter: RGD PMID:15863205 RGD:11252161 NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
JBrowse link
G CDK6 cyclin dependent kinase 6 EXP CTD Direct Evidence: marker/mechanism CTD PMID:18206229 NCBI chr 7:92,604,921...92,836,573
Ensembl chr 7:92,604,921...92,836,573
JBrowse link
G CDKN1B cyclin dependent kinase inhibitor 1B IAGP DNA:deletion: : RGD PMID:9171997 RGD:10450601 NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
JBrowse link
G CDKN2A cyclin dependent kinase inhibitor 2A disease_progression IAGP
IEP
DNA:deletion: :
mRNA,protein:altered expression:bone marrow:
RGD PMID:11064355 PMID:11697625 RGD:11251749, RGD:11252080 NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301
JBrowse link
G CDKN2B cyclin dependent kinase inhibitor 2B susceptibility
treatment
disease_progression
IAGP
IEP
ISO
IDA
DNA:hypermethylation: :
mRNA:decreased expression:granulocyte,monocyte:
DNA:hypermethylation:promoter:
DNA:deletion: :
RGD PMID:25616284 PMID:9001419 PMID:14681685 PMID:27168825 PMID:15863205 More... RGD:11251739, RGD:11252196, RGD:11252167, RGD:11252164, RGD:11252161, RGD:11251749 NCBI chr 9:22,002,903...22,009,313
Ensembl chr 9:22,002,903...22,009,305
JBrowse link
G CEBPA CCAAT enhancer binding protein alpha IAGP
EXP
ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar Annotator: match by term: Acute myelogenous leukemia
CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: AML - Acute myeloid leukemia
ClinVar Annotator: match by term: Leukemia, acute myelogenous
ClinVar
CTD
OMIM
PMID:11242107 PMID:12661007 PMID:12692518 PMID:14726504 PMID:15575056 More... NCBI chr19:33,299,934...33,302,534
Ensembl chr19:33,299,934...33,302,534
JBrowse link
G CEBPD CCAAT enhancer binding protein delta EXP CTD Direct Evidence: marker/mechanism CTD PMID:17234736 NCBI chr 8:47,736,913...47,738,164
Ensembl chr 8:47,736,913...47,738,164
JBrowse link
G CFHR1 complement factor H related 1 susceptibility IAGP DNA:deletion: : RGD PMID:26317246 RGD:11341662 NCBI chr 1:196,819,731...196,832,189
Ensembl chr 1:196,819,731...196,832,189
JBrowse link
G CFLAR CASP8 and FADD like apoptosis regulator disease_progression IEP RGD PMID:23167276 RGD:11341679 NCBI chr 2:201,116,164...201,176,687
Ensembl chr 2:201,116,154...201,176,687
JBrowse link
G CHI3L1 chitinase 3 like 1 severity IEP protein:increased secretion:serum (human) RGD PMID:16361549 RGD:4892644 NCBI chr 1:203,178,931...203,186,704
Ensembl chr 1:203,178,931...203,186,704
JBrowse link
G CHIC2 cysteine rich hydrophobic domain 2 IAGP OMIM NCBI chr 4:54,009,789...54,091,879
Ensembl chr 4:54,009,789...54,064,605
JBrowse link
G CHMP5 charged multivesicular body protein 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17708794 NCBI chr 9:33,265,049...33,282,070
Ensembl chr 9:33,264,879...33,282,070
JBrowse link
G CNR2 cannabinoid receptor 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:15039279 NCBI chr 1:23,870,515...23,913,362
Ensembl chr 1:23,870,515...23,913,362
JBrowse link
G CREBBP CREB binding protein IAGP
ISS
DNA:translocations:intron:IVS2 (human)
OMIM:601626
MouseDO
RGD
PMID:12461753 RGD:734819 NCBI chr16:3,725,054...3,880,713
Ensembl chr16:3,725,054...3,880,713
JBrowse link
G CSF1R colony stimulating factor 1 receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:1390197 NCBI chr 5:150,053,295...150,113,365
Ensembl chr 5:150,053,291...150,113,372
JBrowse link
G CSF2 colony stimulating factor 2 treatment IDA
EXP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:21441929 PMID:1826536 RGD:10449528 NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
JBrowse link
G CSF3 colony stimulating factor 3 treatment IDA
EXP
CTD Direct Evidence: therapeutic CTD
RGD
PMID:7528855 PMID:10673519 RGD:11039033 NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
JBrowse link
G CSF3R colony stimulating factor 3 receptor disease_progression
susceptibility
IAGP
ISO
ClinVar Annotator: match by term: Acute myelocytic leukemia
associated with Severe Congenital Neutropenia;DNA:nonsense mutation:cds:
ClinVar
RGD
PMID:23604229 PMID:23634996 PMID:23656643 PMID:24081659 PMID:24403076 More... RGD:10450468, RGD:10450487, RGD:10450470 NCBI chr 1:36,466,043...36,483,314
Ensembl chr 1:36,466,043...36,483,278
JBrowse link
G CST3 cystatin C EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr20:23,626,706...23,637,955
Ensembl chr20:23,626,706...23,638,473
JBrowse link
G CTLA4 cytotoxic T-lymphocyte associated protein 4 IAGP DNA:SNP:3'UTR:rs3087243(human) RGD PMID:19092854 RGD:11344911 NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
JBrowse link
G CTNNA1 catenin alpha 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr 5:138,753,425...138,935,034
Ensembl chr 5:138,610,967...138,935,034
JBrowse link
G CTSH cathepsin H EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr15:78,921,058...78,945,046
Ensembl chr15:78,921,058...78,949,574
JBrowse link
G CTSZ cathepsin Z EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr20:58,995,185...59,007,254
Ensembl chr20:58,985,686...59,008,238
JBrowse link
G CXCR4 C-X-C motif chemokine receptor 4 treatment
disease_progression
IMP
IEP
RGD PMID:26031918 PMID:24035716 RGD:11352265, RGD:11352273 NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 disease_progression
no_association
IAGP DNA:SNP: :6235T>C (human)
DNA:polymorphism: :6235T>C (human)
DNA:SNP: :4889A>G (human)
RGD PMID:19456854 PMID:15996939 PMID:19456854 RGD:10769358, RGD:11352736, RGD:10769358 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
JBrowse link
G CYP2B6 cytochrome P450 family 2 subfamily B member 6 susceptibility IAGP DNA:polymorphism:G15631T RGD PMID:19144407 RGD:6480472 NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
JBrowse link
G CYP2D6 cytochrome P450 family 2 subfamily D member 6 susceptibility
treatment
IAGP DNA:polymorphisms: :
DNA:SNP: :(rs16947)(human)
RGD PMID:11037802 PMID:21518482 RGD:11352820, RGD:11352828 NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
JBrowse link
G DAPK1 death associated protein kinase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:19874806 NCBI chr 9:87,497,228...87,708,634
Ensembl chr 9:87,497,228...87,708,634
JBrowse link
G DDX41 DEAD-box helicase 41 IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar PMID:25741868 PMID:25920683 PMID:26712909 PMID:28547672 PMID:30963592 More... NCBI chr 5:177,511,577...177,516,961
Ensembl chr 5:177,511,577...177,516,961
JBrowse link
G DHX15 DEAH-box helicase 15 EXP CTD Direct Evidence: marker/mechanism CTD PMID:27798625 PMID:29163777 NCBI chr 4:24,527,475...24,584,554
Ensembl chr 4:24,517,441...24,584,554
JBrowse link
G DLEC1 DLEC1 cilia and flagella associated protein treatment IDA DNA:hypermethylation:promoter: RGD PMID:27168825 RGD:11252164 NCBI chr 3:38,039,208...38,124,025
Ensembl chr 3:38,039,205...38,124,025
JBrowse link
G DLEU2 deleted in lymphocytic leukemia 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21441929 NCBI chr13:49,982,549...50,125,541
Ensembl chr13:49,956,670...50,125,720
JBrowse link
G DNMT1 DNA methyltransferase 1 IEP mRNA:increased expression:CD34+ bone marrow cells RGD PMID:11222358 RGD:9588667 NCBI chr19:10,133,346...10,194,953
Ensembl chr19:10,133,342...10,231,286
JBrowse link
G DNMT3A DNA methyltransferase 3 alpha disease_progression
susceptibility
treatment
IEP
IAGP
EXP
IDA
mRNA:increased expression:CD34+ bone marrow cells
ClinVar Annotator: match by term: Acute myeloid leukemia
CTD Direct Evidence: marker/mechanism
DNA:missense mutation:exon:p.R882 (human)
associated with Myelodysplastic Syndromes; DNA:mutations:cds:
DNA:hypomethylation: :
DNA:mutation::
ClinVar
CTD
OMIM
RGD
PMID:21067377 PMID:21518476 PMID:22160010 PMID:22722925 PMID:22744846 More... RGD:9588667, RGD:11041123, RGD:11041122, RGD:11041121, RGD:11041120, RGD:9589067 NCBI chr 2:25,227,874...25,342,590
Ensembl chr 2:25,227,855...25,342,590
JBrowse link
G DNMT3B DNA methyltransferase 3 beta susceptibility
disease_progression
IEP
IAGP
mRNA:increased expression:CD34+ bone marrow cells
DNA:SNP:promoter: C>T46359(human)
DNA:SNPs,haplotype: :rs1569686,rs2424908, rs6087990, rs6119954(human)
RGD PMID:11222358 PMID:16194411 PMID:24069326 PMID:23251566 RGD:9588667, RGD:9589108, RGD:9589103, RGD:9589071 NCBI chr20:32,762,385...32,809,356
Ensembl chr20:32,762,385...32,809,359
JBrowse link
G EHD3 EH domain containing 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr 2:31,234,152...31,269,451
Ensembl chr 2:31,234,152...31,269,451
JBrowse link
G EHMT2 euchromatic histone lysine methyltransferase 2 disease_progression ISO
EXP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:24532712 PMID:24532712 RGD:9589168 NCBI chr 6:31,879,759...31,897,698
Ensembl chr 6:31,879,759...31,897,687
JBrowse link
G EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:19458359 NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365
JBrowse link
G ENAH ENAH actin regulator EXP CTD Direct Evidence: marker/mechanism CTD PMID:26237430 NCBI chr 1:225,486,829...225,653,878
Ensembl chr 1:225,486,765...225,653,142
JBrowse link
G ENO2 enolase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698
JBrowse link
G EPHX1 epoxide hydrolase 1 no_association IAGP
EXP
DNA:SNPs:exon:rs1051740, rs2234922 (human)
CTD Direct Evidence: marker/mechanism
DNA:missense mutations:exon:p.Y113H, p.H139R (human)
DNA:polymorphism
CTD
RGD
PMID:29605894 PMID:22200898 PMID:11849215 PMID:20731606 RGD:11252114, RGD:11252119, RGD:11252115 NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
JBrowse link
G ERCC1 ERCC excision repair 1, endonuclease non-catalytic subunit treatment
no_association
IEP
IAGP
DNA:polymorphism: :p.R399Q (human)
DNA:SNP: :p.Q504K (human)
RGD PMID:18604718 PMID:23397959 PMID:16507781 PMID:20141440 PMID:21942242 RGD:11252170, RGD:11252193, RGD:11252179, RGD:11252173, RGD:11252171 NCBI chr19:45,407,334...45,451,547
Ensembl chr19:45,407,334...45,478,828
JBrowse link
G ERCC2 ERCC excision repair 2, TFIIH core complex helicase subunit disease_progression
no_association
IAGP DNA:polymorphism: :p.K751Q (rs13181) (human)
DNA:SNPs, haplotypes: :p.D312N, p.K751Q (human)
associated with Myeloproliferative Disorders;DNA:polymorphism: :p.K751Q (rs13181) (human)
RGD PMID:20141440 PMID:21394217 PMID:22496165 PMID:23397959 RGD:11252173, RGD:11252209, RGD:11252198, RGD:11252193 NCBI chr19:45,349,837...45,370,573
Ensembl chr19:45,349,837...45,370,918
JBrowse link
G ERG ETS transcription factor ERG EXP CTD Direct Evidence: marker/mechanism CTD PMID:19822134 NCBI chr21:38,367,261...38,661,783
Ensembl chr21:38,380,027...38,661,780
JBrowse link
G ETV6 ETS variant transcription factor 6 IAGP DNA:translocation: :t(5;12)(q31;p13) (human)
ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar Annotator: match by term: Leukemia, acute myelogenous
DNA:deletion: :
ClinVar
OMIM
RGD
PMID:15806161 PMID:25581430 PMID:25741868 PMID:25807284 PMID:31248877 More... RGD:1599805, RGD:10450603, RGD:10450601 NCBI chr12:11,649,674...11,895,377
Ensembl chr12:11,649,674...11,895,377
JBrowse link
G EZH2 enhancer of zeste 2 polycomb repressive complex 2 subunit disease_progression
susceptibility
ISO
IEP
IAGP
mRNA:increased expression:bone marrow, mononuclear cell (human)
DNA:mutations:cds:multiple (human)
RGD PMID:22677129 PMID:21125401 PMID:23099237 RGD:10450874, RGD:10450887, RGD:10450876 NCBI chr 7:148,807,383...148,884,291
Ensembl chr 7:148,807,257...148,884,321
JBrowse link
G F3 coagulation factor III, tissue factor IEP RGD PMID:2617479 RGD:11340207 NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
JBrowse link
G FADD Fas associated via death domain disease_progression IEP RGD PMID:15520222 RGD:11341799 NCBI chr11:70,203,296...70,207,390
Ensembl chr11:70,203,296...70,207,390
JBrowse link
G FANCA FA complementation group A IAGP DNA, mRNA:deletions, decreased expression: :multiple RGD PMID:14749703 RGD:11344889 NCBI chr16:89,737,549...89,816,647
Ensembl chr16:89,726,683...89,816,977
JBrowse link
G FANCC FA complementation group C susceptibility IAGP DNA:polymorphism:cds:p.S26F (human) RGD PMID:12670332 RGD:11046259 NCBI chr 9:95,099,054...95,317,709
Ensembl chr 9:95,099,054...95,426,796
JBrowse link
G FAS Fas cell surface death receptor susceptibility IAGP
EXP
IEP
DNA:polymorphism, haplotype:promoter:-1377 G>A, -670 G>A (human)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:7579353 PMID:12907599 PMID:8870373 RGD:11049150, RGD:11049452 NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
JBrowse link
G FERMT2 FERM domain containing kindlin 2 disease_progression IEP RGD PMID:22391155 RGD:11352307 NCBI chr14:52,857,273...52,951,050
Ensembl chr14:52,857,268...52,952,435
JBrowse link
G FERMT3 FERM domain containing kindlin 3 disease_progression IEP RGD PMID:22391155 RGD:11352307 NCBI chr11:64,205,920...64,223,891
Ensembl chr11:64,206,678...64,223,891
JBrowse link
G FGFR1 fibroblast growth factor receptor 1 treatment IMP RGD PMID:27005999 PMID:23777766 PMID:22683780 RGD:11352310, RGD:11352670, RGD:11352665 NCBI chr 8:38,411,143...38,468,635
Ensembl chr 8:38,400,215...38,468,834
JBrowse link
G FHL2 four and a half LIM domains 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr 2:105,357,712...105,438,529
Ensembl chr 2:105,357,712...105,438,513
JBrowse link
G FLT3 fms related receptor tyrosine kinase 3 treatment
disease_progression
IAGP
EXP
ISO
IEP
ClinVar Annotator: match by term: Leukemia, acute myeloid, reduced survival in, somatic
CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar Annotator: match by term: Leukemia, acute myelogenous
DNA:missense mutation:exon:p.D835Y,D835H(human)
DNA:mutations:cds:
DNA:duplication mutation:cds:
mRNA,protein:increased expression:bone marrow:
ClinVar
CTD
OMIM
RGD
PMID:11091200 PMID:11290608 PMID:11442493 PMID:12384447 PMID:14604974 More... RGD:1598955, RGD:11049497, RGD:11049482, RGD:11049471, RGD:11049467, RGD:11049466 NCBI chr13:28,003,274...28,100,576
Ensembl chr13:28,003,274...28,100,592
JBrowse link
G FOXO1 forkhead box O1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr13:40,555,667...40,666,641
Ensembl chr13:40,555,667...40,666,641
JBrowse link
G FXYD6 FXYD domain containing ion transport regulator 6 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr11:117,836,981...117,877,430
Ensembl chr11:117,836,976...117,877,486
JBrowse link
G GAS2L1 growth arrest specific 2 like 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr22:29,306,650...29,312,787
Ensembl chr22:29,306,582...29,312,785
JBrowse link
G GATA1 GATA binding protein 1 disease_progression IEP RGD PMID:7579412 RGD:10450754 NCBI chr  X:48,786,590...48,794,311
Ensembl chr  X:48,786,540...48,794,311
JBrowse link
G GATA2 GATA binding protein 2 disease_progression IAGP
EXP
IEP
ClinVar Annotator: match by term: Leukemia, acute myeloid, susceptibility to
ClinVar Annotator: match by term: Acute myeloid leukemia
CTD Direct Evidence: marker/mechanism
mRNA:decreased expression:CD34+ bone marrow cell:
ClinVar
CTD
OMIM
RGD
PMID:4508672 PMID:8701948 PMID:20040766 PMID:21242295 PMID:21670465 More... RGD:11049510, RGD:11049515, RGD:11049514 NCBI chr 3:128,479,422...128,493,201
Ensembl chr 3:128,479,427...128,493,201
JBrowse link
G GFI1 growth factor independent 1 transcriptional repressor susceptibility IAGP
EXP
DNA:SNP:cds:c.107G>A(rs34631763)(human)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:17330099 PMID:20075157 RGD:11040450 NCBI chr 1:92,473,043...92,486,925
Ensembl chr 1:92,473,043...92,486,925
JBrowse link
G GFI1B growth factor independent 1B transcriptional repressor IEP mRNA:increased expression:bone marrow cell: RGD PMID:17156408 RGD:11040507 NCBI chr 9:132,945,531...132,993,434
Ensembl chr 9:132,944,000...132,991,687
JBrowse link
G GPATCH1 G-patch domain containing 1 IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar PMID:28492532 NCBI chr19:33,081,181...33,130,542
Ensembl chr19:33,080,899...33,130,542
JBrowse link
G GPI glucose-6-phosphate isomerase IEP protein:increased expression:plasma: RGD PMID:6589021 RGD:11051848 NCBI chr19:34,359,718...34,402,413
Ensembl chr19:34,359,480...34,402,413
JBrowse link
G GPX1 glutathione peroxidase 1 disease_progression
treatment
susceptibility
IAGP
IDA
DNA:SNP: :c.599C>T (rs1050450) (human)
DNA:polymorphism: :p.P198L (human)
RGD PMID:26950655 PMID:22930375 PMID:26823947 RGD:11061784, RGD:11352817, RGD:11061561 NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,176...49,358,353
JBrowse link
G GSKIP GSK3B interacting protein IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar NCBI chr14:96,363,526...96,387,290
Ensembl chr14:96,363,452...96,387,288
JBrowse link
G GSR glutathione-disulfide reductase IEP RGD PMID:24191316 RGD:11059506 NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
JBrowse link
G GSTM1 glutathione S-transferase mu 1 susceptibility
disease_progression
IAGP DNA:methylation: :
DNA:deletion: : (human)
RGD PMID:11488937 PMID:22924777 PMID:18035413 RGD:10450822, RGD:10755405, RGD:10755318 NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
JBrowse link
G GSTP1 glutathione S-transferase pi 1 susceptibility IAGP chemotherapy-induced;
DNA:polymorphism:cds:p.I105V(human)
RGD PMID:11553769 PMID:11906705 PMID:21729529 RGD:10755420, RGD:10755328, RGD:10755422 NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
JBrowse link
G GSTT1 glutathione S-transferase theta 1 no_association
disease_progression
susceptibility
IAGP DNA:deletion: : (human) RGD PMID:9164324 PMID:18035413 PMID:11488937 RGD:10450779, RGD:10755318, RGD:10450822
G GTF2I general transcription factor IIi EXP CTD Direct Evidence: marker/mechanism CTD PMID:18206229 NCBI chr 7:74,657,718...74,760,692
Ensembl chr 7:74,650,231...74,760,692
JBrowse link
G H1-0 H1.0 linker histone EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr22:37,805,229...37,807,432
Ensembl chr22:37,805,229...37,807,432
JBrowse link
G H1-2 H1.2 linker histone, cluster member EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr 6:26,055,740...26,056,470
Ensembl chr 6:26,055,740...26,056,470
JBrowse link
G HGF hepatocyte growth factor EXP CTD Direct Evidence: marker/mechanism CTD PMID:22683780 NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
JBrowse link
G HLA-DQB1 major histocompatibility complex, class II, DQ beta 1 IAGP RGD PMID:20051322 PMID:17237562 RGD:11041763, RGD:11041776 NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
JBrowse link
G HMOX1 heme oxygenase 1 ISO mRNA:increased expression:brain, spleen RGD PMID:19268504 RGD:10755700 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
JBrowse link
G HOXA9 homeobox A9 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22541086 NCBI chr 7:27,162,438...27,165,537
Ensembl chr 7:27,162,438...27,175,180
JBrowse link
G HRAS HRas proto-oncogene, GTPase IAGP ClinVar Annotator: match by term: Leukemia, acute myelogenous
ClinVar Annotator: match by term: Acute myelogenous leukemia
ClinVar Annotator: match by term: Acute myelocytic leukemia
ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 More... NCBI chr11:532,242...535,576
Ensembl chr11:532,242...537,321
JBrowse link
G HSPB1 heat shock protein family B (small) member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,304,295
JBrowse link
G ID2 inhibitor of DNA binding 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
JBrowse link
G IDH1 isocitrate dehydrogenase (NADP(+)) 1 disease_progression IAGP
EXP
DNA:mutation:cds:p.R132(human)
ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar Annotator: match by term: Acute myelogenous leukemia
CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Leukemia, acute myelogenous
DNA:SNP::105C>T (rs11554137)(human)
ClinVar
CTD
RGD
PMID:18772396 PMID:19657110 PMID:19798509 PMID:19818334 PMID:20946881 More... RGD:11522718, RGD:11522721 NCBI chr 2:208,236,227...208,255,071
Ensembl chr 2:208,236,229...208,266,074
JBrowse link
G IDH2 isocitrate dehydrogenase (NADP(+)) 2 disease_progression IAGP
EXP
DNA:mutation:cds:p.R172(human)
ClinVar Annotator: match by term: Acute myelogenous leukemia
CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Acute myeloid leukemia
DNA:mutation:cds:p.R140 (human)
ClinVar
CTD
RGD
PMID:20171147 PMID:20847235 PMID:20946881 PMID:21250968 PMID:21596855 More... RGD:11522718, RGD:11522721 NCBI chr15:90,083,045...90,102,468
Ensembl chr15:90,083,045...90,102,477
JBrowse link
G IFI30 IFI30 lysosomal thiol reductase EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr19:18,173,813...18,178,117
Ensembl chr19:18,173,162...18,178,117
JBrowse link
G IL10 interleukin 10 disease_progression IEP RGD PMID:23357299 RGD:11046264 NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
JBrowse link
G IL1A interleukin 1 alpha treatment IDA RGD PMID:2460157 RGD:11051965 NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
JBrowse link
G IL4R interleukin 4 receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:11918534 NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
JBrowse link
G IL6 interleukin 6 disease_progression
treatment
IEP
IMP
human protein in a rat model RGD PMID:23357299 PMID:8892684 RGD:11046264, RGD:11062010 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
JBrowse link
G INPP4B inositol polyphosphate-4-phosphatase type II B EXP CTD Direct Evidence: marker/mechanism CTD PMID:29415082 NCBI chr 4:142,023,160...142,846,535
Ensembl chr 4:142,023,160...142,847,432
JBrowse link
G INSL6 insulin like 6 IAGP ClinVar Annotator: match by term: Leukemia, acute myelogenous
ClinVar Annotator: match by term: Acute myelogenous leukemia
ClinVar PMID:15781101 PMID:15793561 PMID:15858187 PMID:16081687 PMID:16247455 More... NCBI chr 9:4,991,976...5,185,639
Ensembl chr 9:5,123,880...5,185,647
JBrowse link
G ITGAV integrin subunit alpha V treatment IMP RGD PMID:23770013 RGD:10755448 NCBI chr 2:186,590,056...186,680,901
Ensembl chr 2:186,590,056...186,680,901
JBrowse link
G ITGB3 integrin subunit beta 3 treatment IMP
ISO
RGD PMID:23770013 PMID:23770013 RGD:10755448, RGD:10755448 NCBI chr17:47,253,827...47,313,743
Ensembl chr17:47,253,827...47,313,743
JBrowse link
G JAK1 Janus kinase 1 IAGP ClinVar Annotator: match by term: Leukemia, acute myelogenous ClinVar PMID:16239216 PMID:19139102 PMID:19470474 PMID:19838194 PMID:21436584 More... NCBI chr 1:64,833,229...65,067,746
Ensembl chr 1:64,833,229...65,067,754
JBrowse link
G JAK2 Janus kinase 2 IAGP
EXP
ClinVar Annotator: match by term: Leukemia, acute myelogenous
ClinVar Annotator: match by term: Acute myelogenous leukemia
CTD Direct Evidence: marker/mechanism
ClinVar
CTD
OMIM
PMID:15781101 PMID:15793561 PMID:15858187 PMID:16081687 PMID:16247455 More... NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
JBrowse link
G KAT6A lysine acetyltransferase 6A IAGP human gene in a mouse model;DNA:translocation:exon RGD PMID:12676584 RGD:9590334 NCBI chr 8:41,929,479...42,051,987
Ensembl chr 8:41,929,479...42,051,994
JBrowse link
G KIT KIT proto-oncogene, receptor tyrosine kinase IAGP ClinVar Annotator: match by term: Acute myelogenous leukemia
ClinVar Annotator: match by term: Acute myelocytic leukemia
ClinVar Annotator: match by term: Acute myeloid leukemia
OMIM
ClinVar
PMID:7479840 PMID:7513208 PMID:7691885 PMID:8589724 PMID:9657776 More... NCBI chr 4:54,657,957...54,740,715
Ensembl chr 4:54,657,267...54,740,783
JBrowse link
G KLF1 Kruppel like factor 1 disease_progression IEP RGD PMID:19097174 RGD:10769344 NCBI chr19:12,884,422...12,887,201
Ensembl chr19:12,884,422...12,887,201
JBrowse link
G KMT2A lysine methyltransferase 2A IAGP
EXP
DNA:rearrangements
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:10339604 PMID:26237430 PMID:8361504 RGD:1625285 NCBI chr11:118,436,492...118,526,832
Ensembl chr11:118,436,456...118,526,832
JBrowse link
G KMT2B lysine methyltransferase 2B susceptibility ISO RGD PMID:25079327 RGD:9588599 NCBI chr19:35,718,003...35,738,878
Ensembl chr19:35,717,973...35,738,880
JBrowse link
G KMT2C lysine methyltransferase 2C EXP CTD Direct Evidence: marker/mechanism CTD PMID:24794707 NCBI chr 7:152,134,925...152,436,003
Ensembl chr 7:152,134,922...152,436,644
JBrowse link
G KRAS KRAS proto-oncogene, GTPase IAGP OMIM:601626 DNA:insertion:CDS:amino acid Gly11ins
ClinVar Annotator: match by term: Acute myelogenous leukemia
ClinVar Annotator: match by term: Acute myeloblastic leukemia
ClinVar Annotator: match by term: Leukemia, acute myelogenous
ClinVar
OMIM
RGD
PMID:2278970 PMID:2547513 PMID:3122217 PMID:3627975 PMID:7773929 More... RGD:1600469, RGD:11060151 NCBI chr12:25,205,246...25,250,929
Ensembl chr12:25,205,246...25,250,936
JBrowse link
G LOC100507346 uncharacterized LOC100507346 IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar PMID:25741868 PMID:26467025 PMID:28492532 PMID:28873162 PMID:32321774 NCBI chr 9:95,463,609...95,470,019 JBrowse link
G LOC107984703 uncharacterized LOC107984703 IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar NCBI chr14:95,715,483...95,756,779 JBrowse link
G LOC112272571 Sharpr-MPRA regulatory region 11883 IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar NCBI chr14:96,363,212...96,363,506 JBrowse link
G LPAR1 lysophosphatidic acid receptor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr 9:110,873,263...111,038,998
Ensembl chr 9:110,873,263...111,038,470
JBrowse link
G LPP LIM domain containing preferred translocation partner in lipoma IAGP ClinVar Annotator: match by term: Acute myeloid leukemia OMIM
ClinVar
PMID:25741868 NCBI chr 3:188,153,021...188,890,671
Ensembl chr 3:188,153,284...188,890,671
JBrowse link
G LRP3 LDL receptor related protein 3 IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar PMID:28492532 NCBI chr19:33,194,330...33,208,864
Ensembl chr19:33,177,603...33,208,864
JBrowse link
G LRRC56 leucine rich repeat containing 56 IAGP ClinVar Annotator: match by term: Leukemia, acute myelogenous
ClinVar Annotator: match by term: Acute myelogenous leukemia
ClinVar Annotator: match by term: Acute myelocytic leukemia
ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 More... NCBI chr11:506,462...554,912
Ensembl chr11:537,527...554,912
JBrowse link
G LYL1 LYL1 basic helix-loop-helix family member EXP CTD Direct Evidence: marker/mechanism CTD PMID:16094422 NCBI chr19:13,099,033...13,102,858
Ensembl chr19:13,099,033...13,103,161
JBrowse link
G MALAT1 metastasis associated lung adenocarcinoma transcript 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:29119387 NCBI chr11:65,497,738...65,506,516
Ensembl chr11:65,497,688...65,506,516
JBrowse link
G MDM2 MDM2 proto-oncogene disease_progression IEP RGD PMID:11064355 RGD:11251749 NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
JBrowse link
G MECOM MDS1 and EVI1 complex locus EXP CTD Direct Evidence: marker/mechanism CTD PMID:30472098 NCBI chr 3:169,083,507...169,663,712
Ensembl chr 3:169,083,499...169,663,775
JBrowse link
G MEFV MEFV innate immuity regulator, pyrin susceptibility IAGP DNA:polymorphisms:cds:p.M694V,E148Q(human) RGD PMID:22351163 RGD:11531114 NCBI chr16:3,242,027...3,256,633
Ensembl chr16:3,242,027...3,256,633
JBrowse link
G MET MET proto-oncogene, receptor tyrosine kinase EXP CTD Direct Evidence: marker/mechanism CTD PMID:22683780 NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377
JBrowse link
G MIR155 microRNA 155 IEP miRNA:increased expression:blood
miRNA:decreased expression:peripheral blood mononuclear cell
RGD PMID:28989535 PMID:26923190 RGD:24922214, RGD:25671477 NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
JBrowse link
G MIR181A1HG MIR181A1 host gene IAGP ClinVar Annotator: match by term: Acute myeloid leukemia with maturation ClinVar PMID:29254171 PMID:33116287 NCBI chr 1:198,808,003...198,937,429
Ensembl chr 1:198,777,861...198,937,471
JBrowse link
G MLF1 myeloid leukemia factor 1 TAS DNA:translocation:fusion_protein RGD PMID:15659732 RGD:1600902 NCBI chr 3:158,571,194...158,606,456
Ensembl chr 3:158,571,163...158,607,252
JBrowse link
G MLLT10 MLLT10 histone lysine methyltransferase DOT1L cofactor IAGP ClinVar Annotator: match by term: Acute myeloid leukemia OMIM
ClinVar
PMID:25741868 NCBI chr10:21,533,756...21,743,630
Ensembl chr10:21,524,646...21,743,630
JBrowse link
G MN1 MN1 proto-oncogene, transcriptional regulator EXP CTD Direct Evidence: marker/mechanism CTD PMID:19822134 NCBI chr22:27,748,277...27,801,756
Ensembl chr22:27,748,277...27,801,756
JBrowse link
G MTHFR methylenetetrahydrofolate reductase IAGP DNA:SNPs: :677C>T, 1298A>C(human) RGD PMID:17156840 RGD:10449408 NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
JBrowse link
G MTRR 5-methyltetrahydrofolate-homocysteine methyltransferase reductase susceptibility IAGP DNA:polymorphism: :66A>G(human) RGD PMID:18774170 RGD:11075096 NCBI chr 5:7,850,859...7,901,113
Ensembl chr 5:7,851,186...7,906,025
JBrowse link
G MX1 MX dynamin like GTPase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr21:41,420,558...41,459,214
Ensembl chr21:41,420,020...41,470,071
JBrowse link
G MYBL2 MYB proto-oncogene like 2 ISS OMIM:601626 MouseDO NCBI chr20:43,667,114...43,716,482
Ensembl chr20:43,667,019...43,716,495
JBrowse link
G MYC MYC proto-oncogene, bHLH transcription factor EXP CTD Direct Evidence: marker/mechanism CTD PMID:25956709 NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
JBrowse link
G MYH11 myosin heavy chain 11 EXP CTD Direct Evidence: marker/mechanism CTD PMID:18206229 PMID:27798625 NCBI chr16:15,703,135...15,857,028
Ensembl chr16:15,703,135...15,857,028
JBrowse link
G NAT2 N-acetyltransferase 2 susceptibility
no_association
IAGP DNA:polymorphisms,haplotype: :
DNA:polymorphism: :
RGD PMID:21888617 PMID:11352872 RGD:11532769, RGD:11532773 NCBI chr 8:18,386,301...18,401,218
Ensembl chr 8:18,391,282...18,401,218
JBrowse link
G NCOA2 nuclear receptor coactivator 2 IAGP human gene in a mouse model;DNA:translocation:exon RGD PMID:12676584 RGD:9590334 NCBI chr 8:70,109,782...70,456,446
Ensembl chr 8:70,109,782...70,403,808
JBrowse link
G NECTIN2 nectin cell adhesion molecule 2 EXP CTD Direct Evidence: therapeutic CTD PMID:29855615 NCBI chr19:44,846,297...44,889,223
Ensembl chr19:44,846,175...44,889,223
JBrowse link
G NF1 neurofibromin 1 disease_progression
severity
IEP
EXP
IAGP
CTD Direct Evidence: marker/mechanism
DNA:deletion: :
CTD
RGD
PMID:21441929 PMID:25822087 PMID:12518368 PMID:23460398 RGD:12754447, RGD:12789444 NCBI chr17:31,094,927...31,377,677
Ensembl chr17:31,094,927...31,382,116
JBrowse link
G NOS3 nitric oxide synthase 3 disease_progression IAGP DNA:polymorphgism: : 894 G>T(human) RGD PMID:24684492 RGD:11533640 NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
JBrowse link
G NPM1 nucleophosmin 1 onset
disease_progression
IAGP
EXP
ISO
IDA
IMP
TAS
DNA:tandem_duplication:cytoplasmic_localization
ClinVar Annotator: match by term: Acute myeloid leukemia
CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Leukemia, acute myelogenous
DNA:mutation:exon:
DNA:translocation:fusion_protein
ClinVar
CTD
OMIM
RGD
PMID:15659725 PMID:19657110 PMID:19822134 PMID:20026798 PMID:21441929 More... RGD:1600907, RGD:11534990, RGD:11070453, RGD:11049474, RGD:11049471, RGD:1600902 NCBI chr 5:171,387,116...171,410,900
Ensembl chr 5:171,387,116...171,411,810
JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 IAGP DNA:SNP: :609C>T (human) RGD PMID:19456854 RGD:10769358 NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
JBrowse link
G NRAS NRAS proto-oncogene, GTPase disease_progression IAGP
EXP
ISO
ClinVar Annotator: match by term: Acute myelogenous leukemia
ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar Annotator: match by term: Acute myelocytic leukemia
CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Leukemia, acute myelogenous
DNA:missense mutation:cds:
ClinVar
CTD
RGD
PMID:1654209 PMID:2278970 PMID:2407301 PMID:2674680 PMID:2989702 More... RGD:11060151, RGD:11070616, RGD:11535045 NCBI chr 1:114,704,469...114,716,771
Ensembl chr 1:114,704,469...114,716,771
JBrowse link
G NSD1 nuclear receptor binding SET domain protein 1 severity IAGP DNA:translocations:multiple (human)
ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar
RGD
PMID:12807965 PMID:15942875 PMID:17565729 PMID:23190751 PMID:25741868 More... RGD:9590149 NCBI chr 5:177,133,015...177,300,213
Ensembl chr 5:177,131,830...177,300,213
JBrowse link
G NTRK3 neurotrophic receptor tyrosine kinase 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:29119387 NCBI chr15:87,859,751...88,256,739
Ensembl chr15:87,859,751...88,256,791
JBrowse link
G NUP214 nucleoporin 214 IAGP OMIM NCBI chr 9:131,125,586...131,234,663
Ensembl chr 9:131,125,573...131,234,663
JBrowse link
G NUP98 nucleoporin 98 and 96 precursor EXP CTD Direct Evidence: marker/mechanism CTD PMID:21441929 NCBI chr11:3,675,010...3,797,554
Ensembl chr11:3,671,083...3,797,792
JBrowse link
G PDCD1 programmed cell death 1 treatment ISO RGD PMID:26712908 RGD:41410789 NCBI chr 2:241,849,884...241,858,894
Ensembl chr 2:241,849,884...241,858,894
JBrowse link
G PDE4B phosphodiesterase 4B EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr 1:65,792,510...66,374,579
Ensembl chr 1:65,792,514...66,374,579
JBrowse link
G PICALM phosphatidylinositol binding clathrin assembly protein susceptibility IAGP DNA:inversion: :inv(11)(q14q23) OMIM
RGD
PMID:12461747 RGD:1600760 NCBI chr11:85,957,175...86,069,860
Ensembl chr11:85,957,175...86,069,882
JBrowse link
G PIM2 Pim-2 proto-oncogene, serine/threonine kinase EXP CTD Direct Evidence: marker/mechanism CTD PMID:19458359 NCBI chr  X:48,913,182...48,919,024
Ensembl chr  X:48,913,182...48,919,024
JBrowse link
G PLCB1 phospholipase C beta 1 severity IEP mRNA:increased expression:blood (human) RGD PMID:20516454 RGD:11535940 NCBI chr20:8,132,266...8,884,900
Ensembl chr20:8,077,251...8,968,360
JBrowse link
G POU4F1 POU class 4 homeobox 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:18206229 NCBI chr13:78,598,362...78,603,552
Ensembl chr13:78,598,362...78,603,552
JBrowse link
G PRAME PRAME nuclear receptor transcriptional regulator IEP mRNA:increased expression:bone marrow, mononuclear cell (human) RGD PMID:20376794 RGD:11535023 NCBI chr22:22,547,701...22,559,265
Ensembl chr22:22,547,701...22,559,361
JBrowse link
G PSIP1 PC4 and SFRS1 interacting protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr 9:15,464,066...15,510,970
Ensembl chr 9:15,464,066...15,510,995
JBrowse link
G PTCH1 patched 1 IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar PMID:25741868 PMID:26467025 PMID:28492532 PMID:28873162 PMID:32321774 NCBI chr 9:95,442,980...95,516,971
Ensembl chr 9:95,442,980...95,517,057
JBrowse link
G PTPN11 protein tyrosine phosphatase non-receptor type 11 IAGP
EXP
ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar Annotator: match by term: Acute myelogenous leukemia
CTD Direct Evidence: marker/mechanism
ClinVar
CTD
PMID:12717436 PMID:14644997 PMID:15385933 PMID:15710330 PMID:15928039 More... NCBI chr12:112,418,947...112,509,918
Ensembl chr12:112,418,351...112,509,918
JBrowse link
G PVR PVR cell adhesion molecule EXP CTD Direct Evidence: therapeutic CTD PMID:29855615 NCBI chr19:44,643,910...44,666,162
Ensembl chr19:44,643,798...44,666,162
JBrowse link
G PXDN peroxidasin EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr 2:1,631,887...1,744,901
Ensembl chr 2:1,631,887...1,744,852
JBrowse link
G RASGRP1 RAS guanyl releasing protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21441929 NCBI chr15:38,488,103...38,564,814
Ensembl chr15:38,488,103...38,565,575
JBrowse link
G RGS2 regulator of G protein signaling 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr 1:192,809,039...192,812,275
Ensembl chr 1:192,809,039...192,812,275
JBrowse link
G RHPN2 rhophilin Rho GTPase binding protein 2 IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar PMID:28492532 NCBI chr19:32,978,592...33,064,888
Ensembl chr19:32,978,592...33,064,888
JBrowse link
G RTEL1 regulator of telomere elongation helicase 1 IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar PMID:25741868 NCBI chr20:63,657,810...63,696,253
Ensembl chr20:63,657,810...63,696,253
JBrowse link
G RTEL1-TNFRSF6B RTEL1-TNFRSF6B readthrough (NMD candidate) IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar PMID:25741868 NCBI chr20:63,657,810...63,698,698
Ensembl chr20:63,659,300...63,698,684
JBrowse link
G RUNX1 RUNX family transcription factor 1 disease_progression IAGP DNA:translocation
DNA:frameshift mutations, missense mutations, nonsense mutations: :multiple
RGD PMID:12760263 PMID:19808697 PMID:11023523 RGD:6482833, RGD:11251704, RGD:11251692 NCBI chr21:35,372,507...35,580,764
Ensembl chr21:34,787,801...36,004,667
JBrowse link
G RUNX1 RUNX family transcription factor 1 IAGP
EXP
ClinVar Annotator: match by term: Acute myelogenous leukemia
ClinVar Annotator: match by term: Acute myeloid leukemia
CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Leukemia, acute myeloid, m0 subtype
OMIM
ClinVar
CTD
PMID:10068652 PMID:10508512 PMID:11276260 PMID:12200707 PMID:12377125 More... NCBI chr21:34,787,801...35,049,302
Ensembl chr21:34,787,801...36,004,667
JBrowse link
G RUNX1T1 RUNX1 partner transcriptional co-repressor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:18206229 PMID:27798625 NCBI chr 8:91,954,967...92,103,385
Ensembl chr 8:91,954,967...92,103,286
JBrowse link
G RUNX3 RUNX family transcription factor 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:18206229 NCBI chr 1:24,899,511...24,965,138
Ensembl chr 1:24,899,511...24,965,121
JBrowse link
G S100A10 S100 calcium binding protein A10 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr 1:151,982,915...151,993,859
Ensembl chr 1:151,982,915...151,993,859
JBrowse link
G S100A8 S100 calcium binding protein A8 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21971985 NCBI chr 1:153,390,032...153,422,583
Ensembl chr 1:153,390,032...153,391,073
JBrowse link
G SAMHD1 SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 severity IMP human cell line in mouse model RGD PMID:30474474 RGD:149735523 NCBI chr20:36,889,773...36,951,708
Ensembl chr20:36,890,229...36,951,893
JBrowse link
G SEPTIN9 septin 9 EXP CTD Direct Evidence: marker/mechanism CTD PMID:10339604 NCBI chr17:77,281,499...77,500,596
Ensembl chr17:77,280,569...77,500,596
JBrowse link
G SF3B1 splicing factor 3b subunit 1 IAGP ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar Annotator: match by term: Leukemia, acute myelogenous
ClinVar PMID:21909114 PMID:21995386 PMID:23395771 PMID:23634996 PMID:26619011 NCBI chr 2:197,389,784...197,435,093
Ensembl chr 2:197,388,515...197,435,079
JBrowse link
G SF3B2 splicing factor 3b subunit 2 IAGP ClinVar Annotator: match by term: Leukemia, acute myelogenous ClinVar PMID:26619011 NCBI chr11:66,052,364...66,069,308
Ensembl chr11:66,050,729...66,069,308
JBrowse link
G SGK1 serum/glucocorticoid regulated kinase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr 6:134,169,256...134,318,112
Ensembl chr 6:134,169,248...134,318,112
JBrowse link
G SH3GL1 SH3 domain containing GRB2 like 1, endophilin A2 IAGP ClinVar Annotator: match by term: Acute myeloid leukemia OMIM
ClinVar
PMID:25741868 NCBI chr19:4,360,370...4,400,547
Ensembl chr19:4,360,370...4,400,547
JBrowse link
G SLC7A10 solute carrier family 7 member 10 IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar PMID:28492532 NCBI chr19:33,208,664...33,225,850
Ensembl chr19:33,208,664...33,225,850
JBrowse link
G SOCS1 suppressor of cytokine signaling 1 IDA DNA:hypermethylation: : RGD PMID:12759928 RGD:150573811 NCBI chr16:11,254,417...11,256,204
Ensembl chr16:11,254,417...11,256,204
JBrowse link
G SOD2 superoxide dismutase 2 disease_progression IEP
IAGP
protein:increased expression:serum RGD PMID:1596865 PMID:16769586 RGD:11035286, RGD:11035289 NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
JBrowse link
G SPARC secreted protein acidic and cysteine rich EXP CTD Direct Evidence: marker/mechanism CTD PMID:18206229 NCBI chr 5:151,661,096...151,686,915
Ensembl chr 5:151,661,096...151,686,975
JBrowse link
G SPI1 Spi-1 proto-oncogene EXP CTD Direct Evidence: marker/mechanism CTD PMID:26237430 NCBI chr11:47,354,860...47,395,607
Ensembl chr11:47,354,860...47,378,547
JBrowse link
G SPRY4 sprouty RTK signaling antagonist 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25822087 NCBI chr 5:142,310,430...142,325,021
Ensembl chr 5:142,310,427...142,326,455
JBrowse link
G SRSF2 serine and arginine rich splicing factor 2 severity IAGP DNA:mutations:multiple (human) RGD PMID:22431577 RGD:11039017 NCBI chr17:76,734,115...76,737,411
Ensembl chr17:76,734,115...76,737,333
JBrowse link
G SRSF4 serine and arginine rich splicing factor 4 IEP mRNA:decreased expression: (human) RGD PMID:22722453 RGD:11039059 NCBI chr 1:29,147,743...29,181,900
Ensembl chr 1:29,147,743...29,181,900
JBrowse link
G STAT3 signal transducer and activator of transcription 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:19796711 NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,540
JBrowse link
G SVIL supervillin EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr10:29,457,338...29,736,936
Ensembl chr10:29,457,338...29,736,959
JBrowse link
G SYNGR1 synaptogyrin 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr22:39,349,991...39,385,575
Ensembl chr22:39,349,925...39,385,575
JBrowse link
G TCEA2 transcription elongation factor A2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr20:64,055,596...64,072,347
Ensembl chr20:64,049,836...64,072,347
JBrowse link
G TCL1A TCL1 family AKT coactivator A IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar NCBI chr14:95,709,947...95,714,125
Ensembl chr14:95,709,947...95,714,196
JBrowse link
G TCN2 transcobalamin 2 IEP protein:increased expression:: RGD PMID:1059479 RGD:11060122 NCBI chr22:30,607,174...30,627,271
Ensembl chr22:30,607,003...30,627,271
JBrowse link
G TEK TEK receptor tyrosine kinase IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar PMID:19340004 PMID:28492532 NCBI chr 9:27,109,141...27,230,178
Ensembl chr 9:27,109,141...27,230,174
JBrowse link
G TERT telomerase reverse transcriptase disease_progression IEP
IAGP
ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar Annotator: match by term: Leukemia, acute myeloid, susceptibility to
ClinVar Annotator: match by term: Acute myelocytic leukemia
ClinVar Annotator: match by term: Leukemia, acute myelogenous
ClinVar
OMIM
RGD
PMID:15814878 PMID:17460043 PMID:18042801 PMID:18460650 PMID:18753630 More... RGD:11038655 NCBI chr 5:1,253,167...1,295,068
Ensembl chr 5:1,253,147...1,295,068
JBrowse link
G TET2 tet methylcytosine dioxygenase 2 disease_progression IAGP
IEP
DNA:deletions RGD PMID:23389918 PMID:25200248 RGD:11038681, RGD:11038682 NCBI chr 4:105,145,875...105,279,803
Ensembl chr 4:105,145,875...105,279,816
JBrowse link
G TFPI2 tissue factor pathway inhibitor 2 IAGP DNA:hypermethylation:promoter: RGD PMID:22052167 RGD:11060127 NCBI chr 7:93,885,396...93,890,753
Ensembl chr 7:93,885,396...93,890,753
JBrowse link
G TFR2 transferrin receptor 2 disease_progression IEP RGD PMID:15015967 RGD:11062090 NCBI chr 7:100,620,420...100,641,552
Ensembl chr 7:100,620,416...100,642,779
JBrowse link
G TGM6 transglutaminase 6 IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar PMID:21106500 PMID:23206699 PMID:24755948 PMID:25253745 PMID:26467025 More... NCBI chr20:2,380,901...2,432,753
Ensembl chr20:2,380,901...2,432,753
JBrowse link
G TMEM127 transmembrane protein 127 IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar PMID:20923864 PMID:25741868 PMID:28492532 NCBI chr 2:96,248,514...96,265,997
Ensembl chr 2:96,248,514...96,265,997
JBrowse link
G TNFSF10 TNF superfamily member 10 EXP CTD Direct Evidence: therapeutic CTD PMID:12780785 NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
JBrowse link
G TNFSF8 TNF superfamily member 8 EXP CTD Direct Evidence: marker/mechanism CTD PMID:9058727 PMID:10512160 PMID:11918534 NCBI chr 9:114,893,343...114,930,595
Ensembl chr 9:114,893,343...114,930,595
JBrowse link
G TNFSF9 TNF superfamily member 9 IEP protein:increased expression:serum (human) RGD PMID:11564827 RGD:2317350 NCBI chr19:6,531,026...6,535,924
Ensembl chr19:6,531,026...6,535,924
JBrowse link
G TP53 tumor protein p53 disease_progression
treatment
IAGP
ISO
IEP
DNA:mutation: :
ClinVar Annotator: match by term: Acute myelogenous leukemia
ClinVar Annotator: match by term: Acute myelocytic leukemia
ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar Annotator: match by term: Leukemia, acute myelogenous
CTD Direct Evidence: marker/mechanism
DNA:mutations: :
ClinVar
CTD
RGD
PMID:1359493 PMID:1565143 PMID:1565144 PMID:1569604 PMID:1631137 More... RGD:11073714, RGD:11057925, RGD:11075071 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
JBrowse link
G TRH thyrotropin releasing hormone EXP CTD Direct Evidence: marker/mechanism CTD PMID:18206229 NCBI chr 3:129,974,720...129,977,935
Ensembl chr 3:129,974,688...129,977,935
JBrowse link
G TRIO trio Rho guanine nucleotide exchange factor EXP CTD Direct Evidence: marker/mechanism CTD PMID:18206229 NCBI chr 5:14,143,342...14,510,204
Ensembl chr 5:14,143,342...14,532,128
JBrowse link
G TSC1 TSC complex subunit 1 IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar PMID:25741868 PMID:28492532 NCBI chr 9:132,891,349...132,945,378
Ensembl chr 9:132,891,348...132,946,874
JBrowse link
G TSC2 TSC complex subunit 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:19250671 NCBI chr16:2,047,985...2,089,491
Ensembl chr16:2,047,967...2,089,491
JBrowse link
G TUBB2A tubulin beta 2A class IIa EXP CTD Direct Evidence: marker/mechanism CTD PMID:17330099 NCBI chr 6:3,153,666...3,157,544
Ensembl chr 6:3,153,497...3,157,544
JBrowse link
G TUNAR TCL1 upstream neural differentiation-associated RNA IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar NCBI chr14:95,876,392...95,925,571
Ensembl chr14:95,866,587...95,925,663
JBrowse link
G TYMS thymidylate synthetase susceptibility IAGP DNA:repeats,insertion/deletion:5'UTR, 3'UTR: RGD PMID:18774170 RGD:11075096 NCBI chr18:657,653...673,578
Ensembl chr18:657,653...673,578
JBrowse link
G U2AF1 U2 small nuclear RNA auxiliary factor 1 IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar PMID:22158538 PMID:23029227 PMID:23861105 PMID:24498085 PMID:26619011 NCBI chr21:43,092,956...43,107,578
Ensembl chr21:43,092,956...43,107,570
JBrowse link
G VEGFA vascular endothelial growth factor A disease_progression IAGP DNA:SNP,haplotype: :(rs3025039),(rs699947),(rs833061)(human) RGD PMID:17983459 RGD:13432134 NCBI chr 6:43,770,209...43,786,487
Ensembl chr 6:43,770,184...43,786,487
JBrowse link
G VOPP1 VOPP1 WW domain binding protein EXP CTD Direct Evidence: marker/mechanism CTD PMID:18206229 NCBI chr 7:55,434,964...55,572,502
Ensembl chr 7:55,436,056...55,572,988
JBrowse link
G VSIG4 V-set and immunoglobulin domain containing 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:18206229 NCBI chr  X:66,021,738...66,040,080
Ensembl chr  X:66,021,738...66,040,125
JBrowse link
G WDR88 WD repeat domain 88 IAGP ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar PMID:28492532 NCBI chr19:33,132,114...33,175,799
Ensembl chr19:33,132,090...33,175,799
JBrowse link
G WT1 WT1 transcription factor IAGP
EXP
ClinVar Annotator: match by term: Acute myeloid leukemia
CTD Direct Evidence: marker/mechanism
ClinVar
CTD
PMID:19822134 PMID:24374862 PMID:24422723 PMID:24521058 PMID:24659740 More... NCBI chr11:32,387,775...32,435,539
Ensembl chr11:32,387,775...32,435,564
JBrowse link
G ZBTB7A zinc finger and BTB domain containing 7A EXP CTD Direct Evidence: marker/mechanism CTD PMID:27798625 NCBI chr19:4,043,303...4,066,899
Ensembl chr19:4,043,303...4,066,899
JBrowse link
G ZFP91 ZFP91 zinc finger protein, atypical E3 ubiquitin ligase ISO RGD PMID:12738986 RGD:727221 NCBI chr11:58,579,063...58,621,550
Ensembl chr11:58,579,063...58,621,550
JBrowse link
G ZRSR2 zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 IAGP DNA:missense mutations:multiple (human)
associated with aging
RGD PMID:25550361 PMID:32027246 RGD:151232299, RGD:151347178 NCBI chr  X:15,790,484...15,823,260
Ensembl chr  X:15,790,156...15,830,694
JBrowse link
Acute Myelomonocytic Leukemia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ARHGAP26 Rho GTPase activating protein 26 IAGP juvenile myelomonocytic leukemia, OMIM:607785 translocation t(5;11)(q31;q23) fusing ARHGAP26 to MLL in one allele and point mutation A1255G/Asn417Ser or one of two insertions in second allele RGD PMID:10908648 RGD:1599311 NCBI chr 5:142,770,377...143,229,011
Ensembl chr 5:142,770,377...143,229,011
JBrowse link
G CBFB core-binding factor subunit beta susceptibility IAGP
EXP
DNA:inversion: :inv(16)(p13q22)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:10958941 PMID:8351518 RGD:1599543 NCBI chr16:67,029,149...67,101,058
Ensembl chr16:67,028,984...67,101,058
JBrowse link
G CDKN2B cyclin dependent kinase inhibitor 2B ISO RGD PMID:14681685 RGD:11252167 NCBI chr 9:22,002,903...22,009,313
Ensembl chr 9:22,002,903...22,009,305
JBrowse link
G FLT3 fms related receptor tyrosine kinase 3 treatment IMP RGD PMID:22187040 RGD:11049503 NCBI chr13:28,003,274...28,100,576
Ensembl chr13:28,003,274...28,100,592
JBrowse link
G GMPS guanine monophosphate synthase IAGP treatment-related acute type M4 myeloid leukemia; chromosomal translocation resulted in a fusion of MLL and GMPS genes RGD PMID:11110714 RGD:1598998 NCBI chr 3:155,869,430...155,944,020
Ensembl chr 3:155,870,650...155,944,020
JBrowse link
G KMT2A lysine methyltransferase 2A EXP CTD Direct Evidence: marker/mechanism CTD PMID:8282816 NCBI chr11:118,436,492...118,526,832
Ensembl chr11:118,436,456...118,526,832
JBrowse link
G MYH11 myosin heavy chain 11 EXP CTD Direct Evidence: marker/mechanism CTD PMID:10958941 NCBI chr16:15,703,135...15,857,028
Ensembl chr16:15,703,135...15,857,028
JBrowse link
acute promyelocytic leukemia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCA1 ATP binding cassette subfamily A member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:32929351 NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
JBrowse link
G AKT1 AKT serine/threonine kinase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12556562 NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
JBrowse link
G AQP9 aquaporin 9 EXP CTD Direct Evidence: marker/mechanism CTD PMID:23563754 NCBI chr15:58,138,169...58,185,911
Ensembl chr15:58,138,169...58,185,911
JBrowse link
G ASXL1 ASXL transcriptional regulator 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26285909 NCBI chr20:32,358,331...32,439,319
Ensembl chr20:32,358,330...32,439,319
JBrowse link
G BIRC5 baculoviral IAP repeat containing 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:27770503 NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
JBrowse link
G CD44 CD44 molecule (Indian blood group) EXP CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:16208414 PMID:17349212 NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
JBrowse link
G CDKN2B cyclin dependent kinase inhibitor 2B disease_progression IDA DNA:hyprmethylation:promoter: RGD PMID:12750706 RGD:11252187 NCBI chr 9:22,002,903...22,009,313
Ensembl chr 9:22,002,903...22,009,305
JBrowse link
G CEBPA CCAAT enhancer binding protein alpha EXP CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:16788101 PMID:26285909 NCBI chr19:33,299,934...33,302,534
Ensembl chr19:33,299,934...33,302,534
JBrowse link
G CEBPE CCAAT enhancer binding protein epsilon EXP CTD Direct Evidence: therapeutic CTD PMID:16788101 NCBI chr14:23,117,306...23,119,255
Ensembl chr14:23,117,036...23,120,256
JBrowse link
G DAPK2 death associated protein kinase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28978663 NCBI chr15:63,907,036...64,046,485
Ensembl chr15:63,907,036...64,072,033
JBrowse link
G DEFA3 defensin alpha 3 EXP CTD Direct Evidence: therapeutic CTD PMID:16019513 NCBI chr 8:7,015,869...7,018,297
Ensembl chr 8:7,015,869...7,018,297
JBrowse link
G DHCR7 7-dehydrocholesterol reductase EXP CTD Direct Evidence: marker/mechanism CTD PMID:32929351 NCBI chr11:71,434,411...71,448,393
Ensembl chr11:71,428,193...71,452,868
JBrowse link
G DNMT3A DNA methyltransferase 3 alpha EXP CTD Direct Evidence: marker/mechanism CTD PMID:26285909 NCBI chr 2:25,227,874...25,342,590
Ensembl chr 2:25,227,855...25,342,590
JBrowse link
G F3 coagulation factor III, tissue factor IEP
EXP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:16206674 PMID:10726043 RGD:11340216 NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
JBrowse link
G FLT3 fms related receptor tyrosine kinase 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17454189 PMID:24160850 PMID:26285909 NCBI chr13:28,003,274...28,100,576
Ensembl chr13:28,003,274...28,100,592
JBrowse link
G FNDC3B fibronectin type III domain containing 3B EXP CTD Direct Evidence: marker/mechanism CTD PMID:28314734 NCBI chr 3:172,039,578...172,401,669
Ensembl chr 3:172,039,578...172,401,669
JBrowse link
G GLI1 GLI family zinc finger 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:23867347 NCBI chr12:57,459,785...57,472,268
Ensembl chr12:57,459,785...57,472,268
JBrowse link
G GLI2 GLI family zinc finger 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:23867347 NCBI chr 2:120,735,868...120,992,653
Ensembl chr 2:120,735,623...120,992,653
JBrowse link
G GPHN gephyrin EXP CTD Direct Evidence: marker/mechanism CTD PMID:32929351 NCBI chr14:66,508,147...67,735,355
Ensembl chr14:66,507,407...67,181,803
JBrowse link
G GSTT1 glutathione S-transferase theta 1 susceptibility IAGP RGD PMID:21875282 RGD:10755406
G IDH1 isocitrate dehydrogenase (NADP(+)) 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26285909 NCBI chr 2:208,236,227...208,255,071
Ensembl chr 2:208,236,229...208,266,074
JBrowse link
G IDH2 isocitrate dehydrogenase (NADP(+)) 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26285909 NCBI chr15:90,083,045...90,102,468
Ensembl chr15:90,083,045...90,102,477
JBrowse link
G IFNG interferon gamma EXP CTD Direct Evidence: marker/mechanism CTD PMID:22617429 NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
JBrowse link
G IL17A interleukin 17A EXP CTD Direct Evidence: marker/mechanism CTD PMID:22617429 NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
JBrowse link
G IRF2BP2 interferon regulatory factor 2 binding protein 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25583766 NCBI chr 1:234,604,269...234,610,178
Ensembl chr 1:234,604,269...234,610,178
JBrowse link
G ITGAL integrin subunit alpha L EXP CTD Direct Evidence: marker/mechanism CTD PMID:16764927 NCBI chr16:30,472,742...30,523,185
Ensembl chr16:30,472,658...30,523,567
JBrowse link
G ITGAM integrin subunit alpha M EXP CTD Direct Evidence: marker/mechanism CTD PMID:16764927 NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
JBrowse link
G ITGAX integrin subunit alpha X EXP CTD Direct Evidence: marker/mechanism CTD PMID:16764927 NCBI chr16:31,355,176...31,382,999
Ensembl chr16:31,355,134...31,382,999
JBrowse link
G ITGB2 integrin subunit beta 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16764927 NCBI chr21:44,885,953...44,928,815
Ensembl chr21:44,885,953...44,931,989
JBrowse link
G KIT KIT proto-oncogene, receptor tyrosine kinase EXP CTD Direct Evidence: marker/mechanism CTD PMID:26285909 NCBI chr 4:54,657,957...54,740,715
Ensembl chr 4:54,657,267...54,740,783
JBrowse link
G KMT2E lysine methyltransferase 2E (inactive) severity IEP mRNA:decreased expression:peripheral blood, bone marrow, mononuclear cells (human) RGD PMID:24796963 RGD:9588539 NCBI chr 7:105,014,205...105,115,019
Ensembl chr 7:104,940,943...105,115,019
JBrowse link
G LAT2 linker for activation of T cells family member 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:32587277 NCBI chr 7:74,210,006...74,229,834
Ensembl chr 7:74,199,652...74,229,834
JBrowse link
G LEP leptin EXP CTD Direct Evidence: marker/mechanism CTD PMID:32929351 NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
JBrowse link
G LTC4S leukotriene C4 synthase EXP CTD Direct Evidence: marker/mechanism CTD PMID:32929351 NCBI chr 5:179,793,986...179,796,647
Ensembl chr 5:179,793,980...179,796,647
JBrowse link
G ME1 malic enzyme 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:32929351 NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
JBrowse link
G MIR15A microRNA 15a EXP CTD Direct Evidence: therapeutic CTD PMID:21056550 NCBI chr13:50,049,119...50,049,201
Ensembl chr13:50,049,119...50,049,201
JBrowse link
G MIR16-1 microRNA 16-1 EXP CTD Direct Evidence: therapeutic CTD PMID:21056550 NCBI chr13:50,048,973...50,049,061
Ensembl chr13:50,048,973...50,049,061
JBrowse link
G MTARC2 mitochondrial amidoxime reducing component 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:32929351 NCBI chr 1:220,748,322...220,784,815
Ensembl chr 1:220,748,225...220,784,815
JBrowse link
G MYC MYC proto-oncogene, bHLH transcription factor onset IMP
IEP
mRNA:increased expression:promyelocyte: RGD PMID:21059853 PMID:21059853 RGD:11532756, RGD:11532756 NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
JBrowse link
G NCAM1 neural cell adhesion molecule 1 disease_progression IEP RGD PMID:24296270 RGD:40907062 NCBI chr11:112,961,420...113,278,436
Ensembl chr11:112,961,247...113,278,436
JBrowse link
G NPM1 nucleophosmin 1 TAS
EXP
DNA:translocation:fusion_protein
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:14508522 PMID:26285909 PMID:15659732 RGD:1600902 NCBI chr 5:171,387,116...171,410,900
Ensembl chr 5:171,387,116...171,411,810
JBrowse link
G NRAS NRAS proto-oncogene, GTPase EXP CTD Direct Evidence: marker/mechanism CTD PMID:26285909 NCBI chr 1:114,704,469...114,716,771
Ensembl chr 1:114,704,469...114,716,771
JBrowse link
G NUMA1 nuclear mitotic apparatus protein 1 IAGP OMIM NCBI chr11:72,002,864...72,080,542
Ensembl chr11:72,002,864...72,080,693
JBrowse link
G PLAT plasminogen activator, tissue type IEP protein:increased expression:leukocyte (human) RGD PMID:10861807 RGD:11541060 NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
JBrowse link
G PML PML nuclear body scaffold IMP
EXP
human PML/RARA gene fusion in a mouse model
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:8616088 PMID:10742073 PMID:14706140 PMID:16788101 PMID:16835227 More... RGD:41404695 NCBI chr15:73,994,716...74,047,827
Ensembl chr15:73,994,673...74,047,827
JBrowse link
G PPARG peroxisome proliferator activated receptor gamma EXP CTD Direct Evidence: marker/mechanism CTD PMID:32929351 NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
JBrowse link
G PRAME PRAME nuclear receptor transcriptional regulator severity IEP mRNA:increased expression:bone marrow (human) RGD PMID:18815192 RGD:11535037 NCBI chr22:22,547,701...22,559,265
Ensembl chr22:22,547,701...22,559,361
JBrowse link
G PRKAR1A protein kinase cAMP-dependent type I regulatory subunit alpha EXP CTD Direct Evidence: marker/mechanism CTD PMID:17712046 NCBI chr17:68,413,623...68,551,316
Ensembl chr17:68,511,780...68,551,319
JBrowse link
G PTPN11 protein tyrosine phosphatase non-receptor type 11 EXP CTD Direct Evidence: marker/mechanism CTD PMID:32417439 NCBI chr12:112,418,947...112,509,918
Ensembl chr12:112,418,351...112,509,918
JBrowse link
G RAP1GAP RAP1 GTPase activating protein EXP CTD Direct Evidence: marker/mechanism CTD PMID:22614916 NCBI chr 1:21,596,221...21,669,357
Ensembl chr 1:21,596,221...21,669,357
JBrowse link
G RARA retinoic acid receptor alpha TAS
EXP
IAGP
DNA:translocation:fusion_protein
CTD Direct Evidence: marker/mechanism
CTD
OMIM
RGD
PMID:8616088 PMID:10742073 PMID:14508522 PMID:14706140 PMID:16239915 More... RGD:1600902 NCBI chr17:40,309,180...40,357,643
Ensembl chr17:40,309,180...40,357,643
JBrowse link
G RETN resistin EXP CTD Direct Evidence: marker/mechanism CTD PMID:32929351 NCBI chr19:7,669,049...7,670,455
Ensembl chr19:7,669,049...7,670,455
JBrowse link
G ROCK1 Rho associated coiled-coil containing protein kinase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:32417439 NCBI chr18:20,946,906...21,111,813
Ensembl chr18:20,946,906...21,111,813
JBrowse link
G SLIT2 slit guidance ligand 2 EXP CTD Direct Evidence: therapeutic CTD PMID:33120864 NCBI chr 4:20,251,905...20,620,561
Ensembl chr 4:20,251,905...20,620,561
JBrowse link
G SMO smoothened, frizzled class receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:23867347 NCBI chr 7:129,188,633...129,213,545
Ensembl chr 7:129,188,633...129,213,545
JBrowse link
G TET2 tet methylcytosine dioxygenase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26285909 NCBI chr 4:105,145,875...105,279,803
Ensembl chr 4:105,145,875...105,279,816
JBrowse link
G THBD thrombomodulin EXP CTD Direct Evidence: marker/mechanism CTD PMID:16206674 NCBI chr20:23,045,633...23,049,672
Ensembl chr20:23,045,633...23,049,672
JBrowse link
G TMEM127 transmembrane protein 127 IAGP ClinVar Annotator: match by term: Acute promyelocytic leukemia ClinVar PMID:25741868 PMID:28492532 NCBI chr 2:96,248,514...96,265,997
Ensembl chr 2:96,248,514...96,265,997
JBrowse link
G TOP2A DNA topoisomerase II alpha IAGP ClinVar Annotator: match by term: Dna topoisomerase II, resistance to inhibition of, by amsacrine ClinVar PMID:1651812 NCBI chr17:40,388,525...40,417,896
Ensembl chr17:40,388,525...40,417,896
JBrowse link
G TRIB3 tribbles pseudokinase 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:32929351 NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559
JBrowse link
G WT1 WT1 transcription factor EXP CTD Direct Evidence: marker/mechanism CTD PMID:26285909 NCBI chr11:32,387,775...32,435,539
Ensembl chr11:32,387,775...32,435,564
JBrowse link
G ZBTB16 zinc finger and BTB domain containing 16 IAGP
EXP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:23208507 PMID:8387545 RGD:1599922 NCBI chr11:114,059,711...114,256,770
Ensembl chr11:114,059,041...114,256,765
JBrowse link
adult T-cell leukemia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G BIRC5 baculoviral IAP repeat containing 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16497974 NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
JBrowse link
G BMP6 bone morphogenetic protein 6 EXP CTD Direct Evidence: marker/mechanism CTD PMID:18688853 NCBI chr 6:7,726,099...7,881,728
Ensembl chr 6:7,726,099...7,881,728
JBrowse link
G CARD11 caspase recruitment domain family member 11 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26437031 NCBI chr 7:2,906,142...3,043,867
Ensembl chr 7:2,906,142...3,043,867
JBrowse link
G CCR4 C-C motif chemokine receptor 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26437031 NCBI chr 3:32,951,644...32,956,349
Ensembl chr 3:32,951,644...32,956,349
JBrowse link
G CCR7 C-C motif chemokine receptor 7 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26437031 NCBI chr17:40,553,769...40,565,472
Ensembl chr17:40,553,769...40,565,472
JBrowse link
G CD163 CD163 molecule disease_progression IEP protein:increased expression:lymph node tumor (human) RGD PMID:23557330 RGD:42721976 NCBI chr12:7,470,811...7,503,777
Ensembl chr12:7,470,811...7,503,893
JBrowse link
G CD274 CD274 molecule disease_progression IEP RGD PMID:27418641 RGD:41412177 NCBI chr 9:5,450,542...5,470,554
Ensembl chr 9:5,450,503...5,470,566
JBrowse link
G CD28 CD28 molecule EXP CTD Direct Evidence: marker/mechanism CTD PMID:26437031 NCBI chr 2:203,706,465...203,738,912
Ensembl chr 2:203,706,475...203,738,912
JBrowse link
G CD68 CD68 molecule disease_progression IEP protein:increased expression:lymph node tumor (human) RGD PMID:23557330 RGD:42721976 NCBI chr17:7,579,638...7,582,111
Ensembl chr17:7,579,491...7,582,111
JBrowse link
G CD80 CD80 molecule ISO RGD PMID:10590132 RGD:6902938 NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614
JBrowse link
G CD86 CD86 molecule ISO RGD PMID:10590132 RGD:6902938 NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
JBrowse link
G CSNK1A1 casein kinase 1 alpha 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26437031 NCBI chr 5:149,492,982...149,551,439
Ensembl chr 5:149,492,982...149,551,471
JBrowse link
G CSNK2A1 casein kinase 2 alpha 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26437031 NCBI chr20:472,498...543,790
Ensembl chr20:472,498...543,835
JBrowse link
G CSNK2B casein kinase 2 beta EXP CTD Direct Evidence: marker/mechanism CTD PMID:26437031 NCBI chr 6:31,666,080...31,670,067
Ensembl chr 6:31,665,227...31,670,343
JBrowse link
G CTLA4 cytotoxic T-lymphocyte associated protein 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26437031 NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
JBrowse link
G FAS Fas cell surface death receptor susceptibility IAGP
IEP
DNA:polymorphism:promoter: -670 G>A(human)
protein:increased expression:peripheral blood mononuclear cell:
RGD PMID:17962369 PMID:7513372 RGD:11049147, RGD:11049453 NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
JBrowse link
G FOXP3 forkhead box P3 disease_progression EXP
IEP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:23962110 PMID:23797717 RGD:38456007 NCBI chr  X:49,250,438...49,264,710
Ensembl chr  X:49,250,438...49,270,477
JBrowse link
G FYN FYN proto-oncogene, Src family tyrosine kinase EXP CTD Direct Evidence: marker/mechanism CTD PMID:26437031 NCBI chr 6:111,660,332...111,873,452
Ensembl chr 6:111,660,332...111,873,452
JBrowse link
G GATA3 GATA binding protein 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26437031 NCBI chr10:8,045,333...8,075,198
Ensembl chr10:8,045,378...8,075,198
JBrowse link
G GPR183 G protein-coupled receptor 183 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26437031 NCBI chr13:99,294,539...99,307,399
Ensembl chr13:99,294,539...99,307,399
JBrowse link
G HNRNPA2B1 heterogeneous nuclear ribonucleoprotein A2/B1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26437031 NCBI chr 7:26,189,927...26,200,746
Ensembl chr 7:26,171,151...26,201,529
JBrowse link
G ICOS inducible T cell costimulator EXP CTD Direct Evidence: marker/mechanism CTD PMID:26437031 NCBI chr 2:203,936,763...203,961,577
Ensembl chr 2:203,936,763...203,961,577
JBrowse link
G IFNA1 interferon alpha 1 EXP CTD Direct Evidence: therapeutic CTD PMID:20370541 NCBI chr 9:21,440,439...21,441,316
Ensembl chr 9:21,440,439...21,441,316
JBrowse link
G IFNA2 interferon alpha 2 EXP CTD Direct Evidence: therapeutic CTD PMID:12560223 PMID:17077332 NCBI chr 9:21,384,255...21,385,398
Ensembl chr 9:21,384,255...21,385,398
JBrowse link
G IFNG interferon gamma treatment ISO
EXP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:23962110 PMID:8800741 RGD:10755707 NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
JBrowse link
G IKZF2 IKAROS family zinc finger 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26437031 NCBI chr 2:212,999,698...213,152,456
Ensembl chr 2:212,999,691...213,152,427
JBrowse link
G IL10 interleukin 10 IEP
EXP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:23962110 PMID:8704212 RGD:11049460 NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
JBrowse link
G IL2 interleukin 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:23962110 NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
JBrowse link
G IL4 interleukin 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:23962110 NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
JBrowse link
G IL5 interleukin 5 disease_progression IEP protein:increased expression:serum RGD PMID:16425276 RGD:11354942 NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
JBrowse link
G IL6 interleukin 6 IEP protein:increased expression:serum (human) RGD PMID:10374863 RGD:11060275 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
JBrowse link
G IRF4 interferon regulatory factor 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26437031 NCBI chr 6:391,752...411,443
Ensembl chr 6:391,739...411,443
JBrowse link
G JAK3 Janus kinase 3 IAGP DNA:missense mutations: :p.L156P, p.R172Q, p.E183G (human) RGD PMID:21821710 RGD:11531131 NCBI chr19:17,824,782...17,847,982
Ensembl chr19:17,824,780...17,848,071
JBrowse link
G MYB MYB proto-oncogene, transcription factor disease_progression IEP mRNA:splice variants:CD4+ T cell: RGD PMID:27307595 RGD:11532670 NCBI chr 6:135,181,308...135,219,172
Ensembl chr 6:135,181,308...135,219,173
JBrowse link
G NOTCH1 notch receptor 1 IAGP DNA:mutations:multiple (human) RGD PMID:16707600 RGD:1580759 NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048
JBrowse link
G NRAS NRAS proto-oncogene, GTPase disease_progression ISO RGD PMID:21586752 RGD:11535055 NCBI chr 1:114,704,469...114,716,771
Ensembl chr 1:114,704,469...114,716,771
JBrowse link
G PLCG1 phospholipase C gamma 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26437031 NCBI chr20:41,137,543...41,177,626
Ensembl chr20:41,136,960...41,196,801
JBrowse link
G PRKCB protein kinase C beta EXP CTD Direct Evidence: marker/mechanism CTD PMID:26437031 NCBI chr16:23,835,983...24,220,611
Ensembl chr16:23,835,983...24,220,611
JBrowse link
G STAT3 signal transducer and activator of transcription 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:24090995 NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,540
JBrowse link
G TAL2 TAL bHLH transcription factor 2 IAGP RGD PMID:1763056 RGD:1599285 NCBI chr 9:105,662,457...105,663,124
Ensembl chr 9:105,662,457...105,663,124
JBrowse link
G TERF2 telomeric repeat binding factor 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17643074 NCBI chr16:69,355,567...69,386,007
Ensembl chr16:69,355,567...69,408,571
JBrowse link
G TLX1 T cell leukemia homeobox 1 IAGP
EXP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:1717256 PMID:1683261 RGD:1599439 NCBI chr10:101,131,300...101,137,789
Ensembl chr10:101,131,300...101,137,789
JBrowse link
G TNFSF8 TNF superfamily member 8 EXP CTD Direct Evidence: marker/mechanism CTD PMID:9058727 NCBI chr 9:114,893,343...114,930,595
Ensembl chr 9:114,893,343...114,930,595
JBrowse link
G TP53 tumor protein p53 IEA GAD PMID:15118671 RGD:1331525 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
JBrowse link
G TP73 tumor protein p73 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26437031 NCBI chr 1:3,652,516...3,736,201
Ensembl chr 1:3,652,516...3,736,201
JBrowse link
G VAV1 vav guanine nucleotide exchange factor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26437031 NCBI chr19:6,772,708...6,857,361
Ensembl chr19:6,772,708...6,857,366
JBrowse link
alpha-thalassemia myelodysplasia syndrome term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ATRX ATRX chromatin remodeler IAGP ClinVar Annotator: match by term: Acquired hemoglobin H disease
ClinVar Annotator: match by term: Alpha-thalassemia myelodysplasia syndrome
ClinVar
OMIM
PMID:9326931 PMID:10995512 PMID:12858175 PMID:16955409 PMID:20500465 More... NCBI chr  X:77,504,880...77,786,216
Ensembl chr  X:77,504,880...77,786,233
JBrowse link
AMED syndrome term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ADH5 alcohol dehydrogenase 5 (class III), chi polypeptide IAGP ClinVar Annotator: match by term: AMED syndrome, digenic
ClinVar Annotator: match by term: AMED SYNDROME, DIGENIC
OMIM
ClinVar
PMID:25741868 PMID:33355142 NCBI chr 4:99,070,978...99,088,788
Ensembl chr 4:99,070,978...99,088,801
JBrowse link
G ALDH2 aldehyde dehydrogenase 2 family member IAGP ClinVar Annotator: match by term: BONE MARROW FAILURE SYNDROME 7, DIGENIC ClinVar PMID:2987944 PMID:4065146 PMID:6650498 PMID:7180842 PMID:7593603 More... NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
JBrowse link
anaplastic large cell lymphoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ALK ALK receptor tyrosine kinase TAS
EXP
DNA:translocation:fusion_protein
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:16151469 PMID:19503098 PMID:21345110 PMID:22155737 PMID:22920921 More... RGD:1600902 NCBI chr 2:29,192,774...29,921,586
Ensembl chr 2:29,192,774...29,921,586
JBrowse link
G HSP90AA1 heat shock protein 90 alpha family class A member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17157164 NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699
JBrowse link
G IRF4 interferon regulatory factor 4 IAGP DNA:translocation RGD PMID:18987657 RGD:11526155 NCBI chr 6:391,752...411,443
Ensembl chr 6:391,739...411,443
JBrowse link
G JUNB JunB proto-oncogene, AP-1 transcription factor subunit IEP RGD PMID:12145210 RGD:1549449 NCBI chr19:12,791,486...12,793,315
Ensembl chr19:12,791,486...12,793,315
JBrowse link
G NPM1 nucleophosmin 1 TAS DNA:translocation:fusion_protein RGD PMID:15659732 RGD:1600902 NCBI chr 5:171,387,116...171,410,900
Ensembl chr 5:171,387,116...171,411,810
JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit EXP CTD Direct Evidence: marker/mechanism CTD PMID:17261581 NCBI chr11:65,653,601...65,662,916
Ensembl chr11:65,653,599...65,663,090
JBrowse link
G STAT3 signal transducer and activator of transcription 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22155737 NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,540
JBrowse link
G TNFRSF8 TNF receptor superfamily member 8 EXP CTD Direct Evidence: marker/mechanism CTD PMID:10908157 PMID:17261581 NCBI chr 1:12,063,303...12,144,207
Ensembl chr 1:12,063,303...12,144,207
JBrowse link
G TWIST1 twist family bHLH transcription factor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22155737 NCBI chr 7:19,113,047...19,117,636
Ensembl chr 7:19,020,991...19,117,636
JBrowse link
atypical chronic myeloid leukemia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G FGFR1 fibroblast growth factor receptor 1 IMP RGD PMID:15050920 RGD:11352668 NCBI chr 8:38,411,143...38,468,635
Ensembl chr 8:38,400,215...38,468,834
JBrowse link
G SETBP1 SET binding protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:23222956 NCBI chr18:44,680,073...45,068,510
Ensembl chr18:44,680,173...45,068,510
JBrowse link
autosomal dominant sideroblastic anemia 4 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G HSPA9 heat shock protein family A (Hsp70) member 9 IAGP ClinVar Annotator: match by term: Anemia, sideroblastic, autosomal dominant
ClinVar Annotator: match by term: Anemia, sideroblastic, 4
ClinVar
OMIM
PMID:3653362 PMID:20817635 PMID:25741868 PMID:26491070 NCBI chr 5:138,553,756...138,575,401
Ensembl chr 5:138,553,756...138,575,675
JBrowse link
autosomal recessive pyridoxine-refractory sideroblastic anemia 2 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G GLRX5 glutaredoxin 5 EXP CTD Direct Evidence: marker/mechanism CTD NCBI chr14:95,535,050...95,544,714
Ensembl chr14:95,533,503...95,544,724
JBrowse link
G SLC25A38 solute carrier family 25 member 38 IAGP ClinVar Annotator: match by term: Anemia, sideroblastic, 2, pyridoxine-refractory
ClinVar Annotator: match by term: Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive
ClinVar Annotator: match by term: Sideroblastic anemia pyridoxine-refractory autosomal recessive
OMIM
ClinVar
PMID:19412178 PMID:21393332 PMID:24323989 PMID:25326635 PMID:25512395 More... NCBI chr 3:39,383,370...39,397,351
Ensembl chr 3:39,383,370...39,397,351
JBrowse link
autosomal recessive pyridoxine-refractory sideroblastic anemia 3 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G GLRX5 glutaredoxin 5 IAGP ClinVar Annotator: match by term: Sideroblastic anemia 3, pyridoxine-refractory ClinVar
OMIM
PMID:17485548 PMID:20364084 PMID:25342667 PMID:25741868 PMID:26100117 More... NCBI chr14:95,535,050...95,544,714
Ensembl chr14:95,533,503...95,544,724
JBrowse link
Autosomal Sideroblastic Anemia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ARSA arylsulfatase A IAGP ClinVar Annotator: match by term: Autosomal recessive sideroblastic anemia ClinVar PMID:25741868 NCBI chr22:50,622,754...50,628,152
Ensembl chr22:50,622,754...50,628,173
JBrowse link
B-cell acute lymphoblastic leukemia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ERCC4 ERCC excision repair 4, endonuclease catalytic subunit IAGP ClinVar Annotator: match by term: B Acute Lymphoblastic Leukemia ClinVar PMID:23623386 PMID:25741868 NCBI chr16:13,920,154...13,952,348
Ensembl chr16:13,920,138...13,952,348
JBrowse link
G LOC107982234 WT1/WT1-AS bi-directional promoter region IAGP ClinVar Annotator: match by term: B Acute Lymphoblastic Leukemia ClinVar PMID:8621495 PMID:12640141 PMID:16987884 PMID:25741868 PMID:28492532 More... NCBI chr11:32,430,848...32,437,423 JBrowse link
G NF1 neurofibromin 1 IAGP ClinVar Annotator: match by term: B Acute Lymphoblastic Leukemia ClinVar PMID:9536098 PMID:17576681 PMID:23656349 PMID:25741868 PMID:28492532 NCBI chr17:31,094,927...31,377,677
Ensembl chr17:31,094,927...31,382,116
JBrowse link
G WT1 WT1 transcription factor IAGP ClinVar Annotator: match by term: B Acute Lymphoblastic Leukemia ClinVar PMID:8621495 PMID:12640141 PMID:16987884 PMID:25741868 PMID:28492532 More... NCBI chr11:32,387,775...32,435,539
Ensembl chr11:32,387,775...32,435,564
JBrowse link
B-Cell Chronic Lymphocytic Leukemia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCG2 ATP binding cassette subfamily G member 2 (Junior blood group) susceptibility IAGP DNA:SNPs,haplotype: :rs1481012,rs2231142(human) RGD PMID:21918980 RGD:11080977 NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
JBrowse link
G ACOXL acyl-CoA oxidase like EXP CTD Direct Evidence: marker/mechanism CTD PMID:23770605 NCBI chr 2:110,732,573...111,118,548
Ensembl chr 2:110,732,539...111,120,610
JBrowse link
G AICDA activation induced cytidine deaminase disease_progression IEP RGD PMID:21133730 RGD:11039455 NCBI chr12:8,602,170...8,612,859
Ensembl chr12:8,602,155...8,613,242
JBrowse link
G APOE apolipoprotein E disease_progression IAGP RGD PMID:18784741 RGD:11040549 NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
JBrowse link
G ATM ATM serine/threonine kinase EXP CTD Direct Evidence: marker/mechanism CTD PMID:17968022 NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,223,044...108,369,102
JBrowse link
G BCL11A BAF chromatin remodeling complex subunit BCL11A IAGP DNA:translocation:5' utr: (human) RGD PMID:11719382 RGD:11100004 NCBI chr 2:60,450,520...60,553,654
Ensembl chr 2:60,450,520...60,554,467
JBrowse link
G BCL2 BCL2 apoptosis regulator treatment
severity
no_association
IMP
EXP
IEP
IAGP
CTD Direct Evidence: marker/mechanism
protein:increased expression:B cell (human)
DNA:snp:promoter:g.-938C>A (human)
CTD
RGD
PMID:21750559 PMID:23770605 PMID:17296974 PMID:20001236 PMID:17959858 More... RGD:11522735, RGD:11526110, RGD:11526105, RGD:11526104 NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
JBrowse link
G BMF Bcl2 modifying factor EXP CTD Direct Evidence: marker/mechanism CTD PMID:23770605 NCBI chr15:40,087,890...40,108,879
Ensembl chr15:40,087,890...40,108,892
JBrowse link
G BRAF B-Raf proto-oncogene, serine/threonine kinase IAGP ClinVar Annotator: match by term: B-cell chronic lymphocytic leukemia
ClinVar Annotator: match by term: Leukemia, B-cell, chronic
ClinVar PMID:12068308 PMID:12198537 PMID:12692057 PMID:12960123 PMID:14612909 More... NCBI chr 7:140,713,328...140,924,929
Ensembl chr 7:140,719,327...140,924,929
JBrowse link
G BTK Bruton tyrosine kinase treatment IMP
IAGP
ClinVar Annotator: match by term: B-cell chronic lymphocytic leukemia ClinVar
RGD
PMID:24869598 PMID:25741868 PMID:28492532 PMID:23045577 RGD:11040699 NCBI chr  X:101,349,450...101,390,796
Ensembl chr  X:101,349,338...101,390,796
JBrowse link
G C11orf21 chromosome 11 open reading frame 21 EXP CTD Direct Evidence: marker/mechanism CTD PMID:23770605 NCBI chr11:2,295,628...2,303,140
Ensembl chr11:2,295,628...2,303,049
JBrowse link
G CBL Cbl proto-oncogene severity IEP
IDA
mRNA,protein:increased expression:CD5+ B cell:
DNA:hypophosphorylation:CD5+ B cell:
RGD PMID:17804547 PMID:17804547 RGD:11038803, RGD:11038803 NCBI chr11:119,206,339...119,308,149
Ensembl chr11:119,206,298...119,313,926
JBrowse link
G CCDC50 coiled-coil domain containing 50 IDA RGD PMID:19641524 RGD:9685139 NCBI chr 3:191,329,394...191,398,659
Ensembl chr 3:191,329,085...191,398,659
JBrowse link
G CD40 CD40 molecule IMP RGD PMID:20616215 RGD:5490532 NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
JBrowse link
G CD40LG CD40 ligand IMP mouse-human chimeric gene in human RGD PMID:20882050 RGD:11352235 NCBI chr  X:136,648,158...136,660,390
Ensembl chr  X:136,648,158...136,660,390
JBrowse link
G CD5 CD5 molecule EXP CTD Direct Evidence: marker/mechanism CTD PMID:18006695 NCBI chr11:61,093,963...61,127,852
Ensembl chr11:61,102,489...61,127,852
JBrowse link
G CD79B CD79b molecule IEP
IAGP
protein:decreased expression:B lymphocyte, cell surface (human)
DNA:polymorphism:multiple (human)
mRNA, protein:splice variants, alternative forms:exon 3 (human)
RGD PMID:9269755 PMID:10552962 PMID:10090943 RGD:11250403, RGD:151665202, RGD:151665190 NCBI chr17:63,928,740...63,932,331
Ensembl chr17:63,928,740...63,932,336
JBrowse link
G CD86 CD86 molecule severity IEP protein:increased expression:peripheral blood mononuclear cell (human) RGD PMID:25179679 RGD:11354969 NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
JBrowse link
G CDKN2B-AS1 CDKN2B antisense RNA 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:23770605 NCBI chr 9:21,994,791...22,121,097
Ensembl chr 9:21,994,139...22,128,103
JBrowse link
G CPEB1 cytoplasmic polyadenylation element binding protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20062064 NCBI chr15:82,543,201...82,648,795
Ensembl chr15:82,543,201...82,648,861
JBrowse link
G CTLA4 cytotoxic T-lymphocyte associated protein 4 IEP protein:increased expression:T cell RGD PMID:16094420 PMID:15914560 RGD:11344923, RGD:11352246 NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
JBrowse link
G DKC1 dyskerin pseudouridine synthase 1 IEP RGD PMID:18077792 RGD:11251735 NCBI chr  X:154,762,864...154,777,689
Ensembl chr &